<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39731183</article-id><article-id pub-id-type="pmc">PMC11681689</article-id><article-id pub-id-type="publisher-id">5215</article-id><article-id pub-id-type="doi">10.1186/s13054-024-05215-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ohbe</surname><given-names>Hiroyuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Satoh</surname><given-names>Kasumi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Totoki</surname><given-names>Takaaki</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Tanikawa</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shirasaki</surname><given-names>Kasumi</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kuribayashi</surname><given-names>Yoshihide</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Tamura</surname><given-names>Miku</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Takatani</surname><given-names>Yudai</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Ishikura</surname><given-names>Hiroyasu</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nakamura</surname><given-names>Kensuke</given-names></name><address><email>mamashockpapashock@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><collab>J-STAD (JAPAN Sepsis Treatment and Diagnosis) Study Group</collab></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00kcd6x60</institution-id><institution-id institution-id-type="GRID">grid.412757.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 778X</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>Tohoku University Hospital, </institution></institution-wrap>1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/057zh3y96</institution-id><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2169 1048</institution-id><institution>Department of Clinical Epidemiology and Health Economics, School of Public Health, </institution><institution>The University of Tokyo, </institution></institution-wrap>7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03hv1ad10</institution-id><institution-id institution-id-type="GRID">grid.251924.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0725 8504</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>Akita University Graduate School of Medicine, </institution></institution-wrap>1-1-1 Hondo, Akita, 010-8543 Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01y2kdt21</institution-id><institution-id institution-id-type="GRID">grid.444883.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2109 9431</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>Osaka Medical and Pharmaceutical University, </institution></institution-wrap>2-7 Daigakumachi, Takatsuki, Osaka 569-8686 Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/002wydw38</institution-id><institution-id institution-id-type="GRID">grid.430395.8</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>St. Luke&#x02019;s International Hospital, </institution></institution-wrap>9-1 Akashicho, Chuo-ku, Tokyo, 104-8560 Japan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00xsdn005</institution-id><institution-id institution-id-type="GRID">grid.412002.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0615 9100</institution-id><institution>Department of Emergency and Disaster Medicine, </institution><institution>Kanazawa University Hospital, </institution></institution-wrap>13, 1-1 Takara-Machi, Kanazawa 920-8640, Aoba-ku, Sendai, 980-8574 Japan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01nyv7k26</institution-id><institution-id institution-id-type="GRID">grid.412334.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0665 3553</institution-id><institution>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, </institution><institution>Oita University, </institution></institution-wrap>1-1 Idaigaoka, Hasamacho, Yufu, Oita, 879-5593 Japan </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02nycs597</institution-id><institution-id institution-id-type="GRID">grid.415167.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 6806</institution-id><institution>Department of Pharmacy, </institution><institution>Funabashi Municipal Medical Center, </institution></institution-wrap>1-21-1 Kanasugi, Funabashi city, Chiba, Japan </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04k6gr834</institution-id><institution-id institution-id-type="GRID">grid.411217.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0531 2775</institution-id><institution>Department of Primary Care and Emergency Medicine, </institution><institution>Kyoto University Hospital, </institution></institution-wrap>54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507 Japan </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012nfex57</institution-id><institution-id institution-id-type="GRID">grid.415639.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0377 6680</institution-id><institution>Department of Emergency and Critical Care Center, </institution><institution>Rakuwakai Otowa Hospital, </institution></institution-wrap>2 Otowachinji-cho, Yamashina-ku, Kyoto, 607-8062 Japan </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/010hfy465</institution-id><institution-id institution-id-type="GRID">grid.470126.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1767 0473</institution-id><institution>Department of Critical Care Medicine, </institution><institution>Yokohama City University Hospital, </institution></institution-wrap>3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004 Japan </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>28</volume><elocation-id>435</elocation-id><history><date date-type="received"><day>19</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Medical advances in intensive care units (ICUs) have resulted in the emergence of a new patient population&#x02014;those who survive the initial acute phase of critical illness, but require prolonged ICU stays and develop chronic critical symptoms. This condition, often termed Persistent Critical Illness (PerCI) or Chronic Critical Illness (CCI), remains poorly understood and inconsistently reported across studies, resulting in a lack of clinical practice use. This scoping review aims to systematically review and synthesize the existing literature on PerCI/CCI, with a focus on definitions, epidemiology, and outcomes for its translation to clinical practice.</p></sec><sec><title>Methods</title><p id="Par2">A scoping review was conducted using MEDLINE and Scopus, adhering to the PRISMA-ScR guidelines. Peer-reviewed original research articles published until May 31, 2024 that described adult PerCI/CCI in their definitions of patient populations, covariates, and outcomes were included. Data on definitions, epidemiology, and outcomes were extracted by a data charting process from eligible studies and synthesized.</p></sec><sec><title>Results</title><p id="Par3">Ninety-nine studies met the inclusion criteria. Of these studies, 64 used the term CCI, 18 used PerCI, and 17 used other terms. CCI definitions showed greater variability, while PerCI definitions remained relatively consistent, with an ICU stay&#x02009;&#x02265;&#x02009;14&#x000a0;days for CCI and&#x02009;&#x02265;&#x02009;10&#x000a0;days for PerCI being the most common. A meta-analysis of the prevalence of PerCI/CCI among the denominators of &#x0201c;all ICU patients&#x0201d;, &#x0201c;sepsis&#x0201d;, &#x0201c;trauma&#x0201d;, and &#x0201c;COVID-19&#x0201d; showed 11% (95% confidence interval 10&#x02013;12%), 28% (22&#x02013;34%), 24% (15&#x02013;33%), and 35% (20&#x02013;50%), respectively. A meta-analysis of in-hospital mortality was 27% (26&#x02013;29%) and that of one-year mortality was 45% (32&#x02013;58%). Meta-analyses of the prevalence of CCI and PerCI showed 17% (16&#x02013;18%) and 18% (16&#x02013;20%), respectively, and those for in-hospital mortality were 28% (26&#x02013;30%) and 26% (24&#x02013;29%), respectively. Functional outcomes were generally poor, with many survivors requiring long-term care.</p></sec><sec><title>Conclusions</title><p id="Par4">This scoping review synthesized many studies on PerCI/CCI, highlighting the serious impact of PerCI/CCI on patients&#x02019; long-term outcomes. The results obtained underscore the need for consistent terminology with high-quality research for PerCI/CCI. The results obtained provide important information to be used in discussions with patients and families regarding prognosis and care options.</p></sec><sec><title>Graphical abstract</title><p id="Par5">
<graphic position="anchor" xlink:href="13054_2024_5215_Figa_HTML" id="MO6"/>
</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13054-024-05215-4.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Intensive care unit</kwd><kwd>Persistent critical illness</kwd><kwd>Chronic critical illness</kwd><kwd>Scoping review</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par17">Advances in medical technology have improved survival rates in intensive care units (ICU), which has resulted in the emergence of a new patient population&#x02014;those who survive the initial acute phase of critical illness, but require prolonged ICU stays and develop chronic critical symptoms [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. These patients are often termed persistent critical illness (PerCI), chronic critical illness (CCI), post-intensive care syndrome (PICS), and persistent inflammatory, immunosuppressive, and catabolic syndrome (PIICS). There are many overlapping features among these terms, and each has its specific focus [<xref ref-type="bibr" rid="CR3">3</xref>]. Among them, the terms PerCI and CCI focus on the distinction between &#x0201c;acute&#x0201d; and &#x0201c;chronic/persistent&#x0201d;. Many studies have adopted PerCI and CCI because of the simplicity of their definitions, and they also do not require detailed assessments for the physical, cognitive, and mental health domains of the PICS definition or the measurement of biomarkers for the pathophysiological mechanisms of the PIICS definition [<xref ref-type="bibr" rid="CR3">3</xref>]. However, it is debatable whether there is a clinically meaningful difference between CCI and PerCI [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par18">PerCI/CCI is a devastating condition for patients and their families, with poor long-term mortality and morbidity, and it has recently become a serious and growing issue for healthcare systems worldwide [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Despite its importance, the prevalence, definitions, risk factors, prognoses, and outcomes of these patients remain unclear and are inconsistently reported across studies. While several reviews have been conducted on this topic, many are outdated or lack the methodological rigor found in scoping or systematic reviews that comprehensively search and assess original articles [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, there are gaps in the literature and an incomplete understanding of PerCI/CCI. The concept of PerCI/CCI is not currently used in clinical practice due to the lack of organized information; however, it is an important health issue that needs to be recognized and requires interventions in clinical practice.</p><p id="Par19">Therefore, this scoping review aims to systematically review and synthesize the existing literature on PerCI/CCI, with a focus on the definitions, prevalence, risk factors, and outcomes associated with these conditions. Regarding its translation to clinical practice, we seek to provide a comprehensive overview that will inform both clinical practice and future research, as well as support the provision of critical information to patients and their families who face these challenging diagnoses.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Protocol and registration</title><p id="Par20">This scoping review is reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines (the checklist is shown in <xref rid="MOESM2" ref-type="media">Supplementary Material</xref>) [<xref ref-type="bibr" rid="CR14">14</xref>]. The protocol was registered with the UMIN Clinical Trials Registry (UMIN-CTR) a priori (UMIN000054545) on June 1, 2024. The question examined in this scoping review was as follows: &#x0201c;What are the definitions, epidemiology, and outcomes of adults with PerCI/CCI as described in original research articles?&#x0201d;.</p></sec><sec id="Sec4"><title>Eligibility criteria</title><p id="Par21">Peer-reviewed original research articles were included if they were published by May 31, 2024, written in English, involved adult participants, and used terminology to describe PerCI/CCI in the definitions of patient populations, covariates, and outcomes, with definitions explicitly stated in the article. Three reviewers (HO, TT, and KN) reviewed terms for PerCI/CCI and adopted the following five terms: &#x0201c;persistent critical illness&#x0201d;, &#x0201c;chronic critical illness&#x0201d;, &#x0201c;chronic critically ill&#x0201d;, &#x0201c;chronically critically ill&#x0201d;, and &#x0201c;prolonged critical illness&#x0201d;. Studies were excluded if they were unpublished, preprints, conference abstracts without subsequent study publication, studies not in English, review articles, animal studies, or studies on children.</p></sec><sec id="Sec5"><title>Search strategy</title><p id="Par22">We used the bibliographic databases of MEDLINE (via Ovid) and Scopus. The search was performed on June 1, 2024 for MEDLINE and on November 10, 2024 for Scopus and full search strategies may be found in <xref rid="MOESM3" ref-type="media">Supplementary Material</xref>. The final search results were exported into Rayyan [<xref ref-type="bibr" rid="CR15">15</xref>], and duplicates were removed by the duplicate resolution system provided by Rayyan and two independent reviewers (HO and TT). In the first screening, two investigators (HO and TT) independently assessed eligibility by screening the study titles and abstracts after removing duplicates. Five investigators (HO, TT, AT, MT, and KN) then evaluated eligibility based on full-text manuscripts of all publications identified in the first screening. We resolved any disagreement through discussions under the supervision of a senior investigator (HO).</p></sec><sec id="Sec6"><title>Data charting process</title><p id="Par23">Regarding each section on definitions, epidemiology (prevalence, characteristics, and risk factors), and outcomes (prognosis, trajectory, and functional outcome), data-charting forms were jointly developed by two reviewers (HO and AT, KS and YK, and MT and YT, respectively) to identify which variables to extract. The two reviewers independently charted the data, discussed the results, and continuously updated the data-charting form for each section in an iterative process [<xref ref-type="bibr" rid="CR16">16</xref>]. Any disagreements were resolved through discussions between the two reviewers or further adjudication by supervision from one senior investigator (HO). Data charting was implemented using Excel software.</p><sec id="Sec7"><title>Synthesis of results</title><p id="Par24">We created tables to show results for abstracted data. Meta-analyses of prevalence, age, acute physiology and chronic health evaluation (APACHE) II scores, in-hospital mortality, and one-year mortality stratified by the terms for PerCI/CCI were performed because these data were important and there was a sufficient number of articles reporting these data. Meta-analyses were conducted with a random-effects model using the method of DerSimonian and Laird, with the estimate of heterogeneity being taken from the inverse-variance fixed-effect model. A test of whether the summary effect measure was equal to zero was performed and heterogeneity was also quantified using the I<sup>2</sup> statistic (&#x02265;&#x02009;50% indicates moderate heterogeneity). These meta-analyses and the creation of forest plot graphs were performed using &#x0201c;metaprop&#x0201d; for binary variables and &#x0201c;metan&#x0201d; for continuous variables in STATA command [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. When median values were provided for continuous variables, they were used as the mean, and when the interquartile range (IQR) was provided, the standard deviation was calculated from IQR/1.35 [<xref ref-type="bibr" rid="CR19">19</xref>]. Subgroup meta-analyses stratified by &#x0201c;persistent critical illness&#x0201d; and &#x0201c;chronic critical illness&#x0201d; and sensitivity meta-analyses stratified by seven continents were also conducted on prevalence and in-hospital mortality. Serial studies from the same cohort with overlapping observation periods were identified. To avoid double-counting, only the study with the largest population or the most recent study reporting each variable was included in meta-analyses.</p></sec></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Selection of sources of evidence</title><p id="Par25">After the removal of duplicates, 824 citations were identified from searches of electronic databases (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Based on the title and abstract, 615 were excluded, with 209 full-text articles being retrieved and assessed for eligibility. We excluded 2 studies because we were unable to retrieve them. A further 108 studies were excluded because they did not explicitly state the definitions of PerCI/CCI. Therefore, the remaining 99 studies were considered eligible for this review [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR118">118</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Selection of sources of evidence</p></caption><graphic xlink:href="13054_2024_5215_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec10"><title>Characteristics of sources of evidence</title><p id="Par26">The studies&#x02019; author, year, country, type of study, and terminology of PerCI/CCI are presented in Supplemental Table <xref rid="MOESM1" ref-type="media">1</xref>. Of the 99 studies, 64 used the term &#x0201c;chronic critical illness&#x0201d;, 18 used &#x0201c;persistent critical illness&#x0201d;, 9 used &#x0201c;chronic critically ill&#x0201d;, 6 used &#x0201c;prolonged critical illness&#x0201d;, and 2 used &#x0201c;chronically critically ill&#x0201d;. The terms &#x0201c;chronic critically ill&#x0201d;, &#x0201c;prolonged critical illness&#x0201d;, and &#x0201c;chronic critically ill&#x0201d; were mainly used in the 2000s, while the terms &#x0201c;chronic critical illness&#x0201d; and &#x0201c;persistent critical illness&#x0201d; have been used in recent years, with many publications after 2019 (Supplemental Fig. <xref rid="MOESM1" ref-type="media">1</xref>). Serial studies were identified from 6 cohorts and presented in Supplemental Table <xref rid="MOESM1" ref-type="media">2</xref>.</p></sec><sec id="Sec11"><title>Definition</title><p id="Par27">A summary of the definition of PerCI/CCI is shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplemental Table <xref rid="MOESM1" ref-type="media">1</xref>. Although the definition varies widely, most studies used the ICU or mechanical ventilation (MV) duration in the definition. Of the 64 studies that used the term &#x0201c;chronic critical illness&#x0201d;, 49 (76%) involved ICU stays with a specific duration (&#x02265;&#x02009;5 to&#x02009;&#x02265;&#x02009;21&#x000a0;days) with persistent organ dysfunction or additional conditions, 12 (19%) involved MV for a specific duration (&#x02265;&#x02009;7 to&#x02009;&#x02265;&#x02009;21&#x000a0;days) or tracheostomy, and 3 (5%) were other criteria. The most common definition was an ICU stay&#x02009;&#x02265;&#x02009;14&#x000a0;days with persistent organ dysfunction, accounting for 50% (n&#x02009;=&#x02009;32/64). Of the 18 studies that used the term &#x0201c;persistent critical illness&#x0201d;, all 18 focused on ICU stays and the most common criterion was an ICU stay&#x02009;&#x02265;&#x02009;10&#x000a0;days, accounting for 83% (n&#x02009;=&#x02009;15/18). Definitions of the terms &#x0201c;chronic critically ill&#x0201d;, &#x0201c;prolonged critical illness&#x0201d;, and &#x0201c;chronically critically ill&#x0201d; varied across studies, with no duplicated definition being found among studies.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Summary of definitions for PerCI/CCI</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Terminology</th><th align="left">Definition*</th><th align="left">Number</th><th align="left">Percentage (%)</th></tr></thead><tbody><tr><td align="left">Chronic critical illness (CCI)</td><td align="left"/><td align="left">64</td><td char="." align="char"/></tr><tr><td align="left"/><td align="left">ICU stay&#x02009;&#x02265;&#x02009;14&#x000a0;days with persistent organ dysfunction</td><td char="." align="char">32</td><td char="." align="char">50</td></tr><tr><td align="left"/><td align="left">ICU stay&#x02009;&#x02265;&#x02009;8&#x000a0;days and one of six eligible clinical conditions</td><td char="." align="char">5</td><td char="." align="char">8</td></tr><tr><td align="left"/><td align="left">MV&#x02009;&#x02265;&#x02009;7&#x000a0;days</td><td char="." align="char">4</td><td char="." align="char">6</td></tr><tr><td align="left"/><td align="left">ICU stay&#x02009;&#x0003e;&#x02009;14&#x000a0;days</td><td char="." align="char">2</td><td char="." align="char">3</td></tr><tr><td align="left"/><td align="left">ICU stay&#x02009;&#x02265;&#x02009;21&#x000a0;days</td><td char="." align="char">2</td><td char="." align="char">3</td></tr><tr><td align="left"/><td align="left">MV&#x02009;&#x02265;&#x02009;14&#x000a0;days or tracheostomy</td><td char="." align="char">2</td><td char="." align="char">3</td></tr><tr><td align="left">Persistent critical illness (PerCI)</td><td align="left"/><td align="left">18</td><td char="." align="char"/></tr><tr><td align="left"/><td align="left">ICU stay&#x02009;&#x02265;&#x02009;10&#x000a0;days</td><td char="." align="char">15</td><td char="." align="char">83</td></tr></tbody></table><table-wrap-foot><p><italic>PerCI</italic> persistent critical illness; <italic>CCI</italic> chronic critical illness; <italic>ICU</italic> Intensive care unit; <italic>MV</italic> mechanical ventilation</p><p>*Unduplicated definitions are not listed</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec12"><title>Prevalence</title><p id="Par28">Seventy studies reported the prevalence of PerCI/CCI; however, denominators for prevalence calculations varied widely (Supplemental Table <xref rid="MOESM1" ref-type="media">3</xref>). After discussions on the data charting process, we abstracted the prevalence of PerCI/CCI stratified by the denominators of &#x0201c;all ICU patients&#x0201d;, &#x0201c;sepsis&#x0201d;, &#x0201c;trauma&#x0201d;, &#x0201c;corona virus disease 2019 (COVID-19)&#x0201d;, and &#x0201c;Other&#x0201d;. We then excluded 11 studies categorized by &#x0201c;Other&#x0201d; and 18 serial studies and conducted meta-analyses. The overall estimated prevalence of PerCI/CCI in 41 studies regardless of the denominator was 17% (95% confidence interval [CI] 16&#x02013;18%) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The estimated prevalence among the denominators of &#x0201c;all ICU patients&#x0201d;, &#x0201c;sepsis&#x0201d;, &#x0201c;trauma&#x0201d;, and &#x0201c;COVID-19&#x0201d; were 11% (10&#x02013;12%), 28% (22&#x02013;34%), 24% (15&#x02013;33%), and 35% (20&#x02013;50%), respectively. Subgroup meta-analyses showed that the overall estimated prevalence among 23 studies using definitions of the terms &#x0201c;chronic critical illness&#x0201d; was 17% (16&#x02013;18%), while that among 13 studies using &#x0201c;persistent critical illness&#x0201d; was 18% (16&#x02013;20%) (Supplemental Figs. <xref rid="MOESM1" ref-type="media">2</xref>, <xref rid="MOESM1" ref-type="media">3</xref>). The estimated prevalence among denominators of &#x0201c;all ICU patients&#x0201d; were 10% (9&#x02013;11%) and 11% (9&#x02013;14%) for the terms &#x0201c;chronic critical illness&#x0201d; and &#x0201c;persistent critical illness&#x0201d;, respectively. Sensitivity meta-analyses showed that the overall estimated prevalence in North America, Europe, Asia, and South America were 17% (16&#x02013;19%), 20% (18&#x02013;22%), 15% (13&#x02013;17%), and 13% (11&#x02013;15%), respectively (Supplemental Fig. <xref rid="MOESM1" ref-type="media">4</xref>).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Meta-analysis for prevalence of PerCI/CCI. The summary statistics (diamonds) for each stratum and all studies overall are the results of a random effects model. <italic>PerCI</italic> persistent critical illness; <italic>CCI</italic> chronic critical illness; <italic>ICU</italic> intensive care unit; <italic>COVID-19</italic> corona virus infection disease 2019</p></caption><graphic xlink:href="13054_2024_5215_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec13"><title>Characteristics and risk factors</title><p id="Par29">Meta-analyses of 55 studies showed that overall estimated mean age was 62.2 (60.7&#x02013;63.6), while those for the terms &#x0201c;chronic critical illness&#x0201d; and &#x0201c;persistent critical illness&#x0201d; was 63.4 (61.4&#x02013;65.5) and 60.5 (58.4&#x02013;62.6), respectively (Supplemental Fig. <xref rid="MOESM1" ref-type="media">5</xref>). In most studies, males were predominant (60&#x02013;70%) and they often had high rates of MV (&#x0003e;&#x02009;90%) and tracheostomy (approximately 20%) (Supplemental Table <xref rid="MOESM1" ref-type="media">3</xref>). Meta-analyses of 29 studies showed that the overall estimated mean APACHE II score was 18.1 (17.3&#x02013;18.9), while those for the terms &#x0201c;chronic critical illness&#x0201d; and &#x0201c;persistent critical illness&#x0201d; were 19.9 (18.3&#x02013;21.5) and 17.7 (16.2&#x02013;19.2), respectively (Supplemental Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>). None of the studies that examined COVID-19 provided a description of long-COVID.</p><p id="Par30">The most commonly reported risk factors for &#x0201c;chronic critical illness&#x0201d; included an older age (10 studies), higher organ failure score (e.g., APACHE II and sequential organ failure assessment) (8 studies), sepsis (4 studies), MV (4 studies), and injury severity score (4 studies) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> and Supplemental Table&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>). All reported risk factors for &#x0201c;persistent critical illness&#x0201d; had no overlap. Few studies reported risk factors for &#x0201c;chronic critically ill&#x0201d;, &#x0201c;chronically critically ill&#x0201d;, and &#x0201c;prolonged critical illness&#x0201d;. Potential biomarkers for the development of PerCI/CCI were included among risk factors, with two studies reporting PT -INR and albumin and one study using GLP-1, ApoA-I, LDL-C, SIRT2, D7-sPD-L1, the urea-to-creatinine ratio, lymphocytes, the monocyte-to-lymphocyte ratio, and glucose.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Summary of risk factors for &#x0201c;chronic critical illness&#x0201d;</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Terminology</th><th align="left">Risk factors*</th><th align="left">Number</th></tr></thead><tbody><tr><td align="left" rowspan="12">Chronic critical illness (CCI)</td><td align="left">Older age</td><td char="." align="char">10</td></tr><tr><td align="left">Organ failure score defined by SOFA, APACHE, or Denver MOF</td><td char="." align="char">8</td></tr><tr><td align="left">Sepsis</td><td char="." align="char">4</td></tr><tr><td align="left">MV</td><td char="." align="char">4</td></tr><tr><td align="left">Injury severity score</td><td char="." align="char">4</td></tr><tr><td align="left">Shock</td><td char="." align="char">3</td></tr><tr><td align="left">Vasopressor use</td><td char="." align="char">3</td></tr><tr><td align="left">Body mass index</td><td char="." align="char">2</td></tr><tr><td align="left">Charlson Comorbidity Index</td><td char="." align="char">2</td></tr><tr><td align="left">Glasgow coma scale</td><td char="." align="char">2</td></tr><tr><td align="left">Albumin</td><td char="." align="char">2</td></tr><tr><td align="left">PT-INR</td><td char="." align="char">2</td></tr></tbody></table><table-wrap-foot><p><italic>CCI</italic> chronic critical illness; <italic>ICU</italic> intensive care unit; <italic>MV</italic> mechanical ventilation; <italic>SOFA</italic> sequential organ failure assessment; <italic>APACHE</italic> acute physiology and chronic health evaluation; <italic>MOF</italic> multiple organ failure; <italic>PT-INR</italic> prothrombin time-international normalized ratio</p><p>*Unduplicated risk factors are not listed</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec14"><title>Prognosis, trajectory, and functional outcomes</title><p id="Par31">Forty-five studies reported in-hospital mortality (Supplemental Table&#x000a0;<xref rid="MOESM1" ref-type="media">5</xref>), and since &#x0201c;chronic critically ill&#x0201d;, &#x0201c;chronically critically ill&#x0201d;, and &#x0201c;prolonged critical illness&#x0201d; were reported by one study each, a meta-analysis of &#x0201c;chronic critical illness&#x0201d; and &#x0201c;persistent critical illness&#x0201d; was conducted. After the exclusion of 9 serial studies, the overall estimated in-hospital mortality of PerCI/CCI in 32 studies was 27% (95% CI 26&#x02013;29%). Estimated in-hospital mortality was 28% (26&#x02013;30%) for &#x0201c;chronic critical illness&#x0201d; and 26% (24&#x02013;29%) for &#x0201c;persistent critical illness&#x0201d;, with no heterogeneity between groups (p&#x02009;=&#x02009;0.287) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Sensitivity meta-analyses showed that estimated in-hospital mortality in North America, Europe, Asia, and South America were 28% (26&#x02013;30%), 22% (18&#x02013;26%), 43% (16&#x02013;69%), and 50% (42&#x02013;59%), respectively (Supplemental Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>). A meta-analysis of &#x0201c;chronic critical illness&#x0201d; in four studies showed that estimated one-year mortality was 45% (32&#x02013;58%) (Supplemental Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Summary of outcomes for PerCI/CCI</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Outcomes</th><th align="left">Number of studies</th><th align="left">Results of meta-analyses (95%CI)</th><th align="left">Median of studies</th><th align="left">Min&#x02013;max</th></tr></thead><tbody><tr><td align="left" colspan="5">Chronic critical illness (CCI)</td></tr><tr><td align="left">&#x000a0;In-hospital mortality</td><td char="." align="char">20</td><td align="left">28% (26&#x02013;30%)</td><td align="left">&#x02013;</td><td align="left">3&#x02013;61%</td></tr><tr><td align="left">&#x000a0;One-year mortality</td><td char="." align="char">4</td><td align="left">45% (32&#x02013;58%)</td><td align="left">&#x02013;</td><td align="left">27&#x02013;62%</td></tr><tr><td align="left">&#x000a0;Median length of ICU, days</td><td char="." align="char">27</td><td align="left">&#x02013;</td><td align="left">21</td><td align="left">13&#x02013;73</td></tr><tr><td align="left">&#x000a0;Median length of stay, days</td><td char="." align="char">6</td><td align="left">&#x02013;</td><td align="left">43</td><td align="left">31&#x02013;47</td></tr><tr><td align="left">&#x000a0;Median length of MV, days</td><td char="." align="char">13</td><td align="left">&#x02013;</td><td align="left">20</td><td align="left">6&#x02013;53</td></tr><tr><td align="left" colspan="5">&#x000a0;Discharge destinations</td></tr><tr><td align="left"> Home</td><td char="." align="char">6</td><td align="left">&#x02013;</td><td align="left">24%</td><td align="left">11&#x02013;35%</td></tr><tr><td align="left"> Another hospital</td><td char="." align="char">6</td><td align="left">&#x02013;</td><td align="left">16%</td><td align="left">4&#x02013;40%</td></tr><tr><td align="left"> Rehabilitation facilities</td><td char="." align="char">5</td><td align="left">&#x02013;</td><td align="left">26%</td><td align="left">3&#x02013;46%</td></tr><tr><td align="left"> Nursing facilities</td><td char="." align="char">6</td><td align="left">&#x02013;</td><td align="left">16%</td><td align="left">1&#x02013;39%</td></tr><tr><td align="left"> Hospice</td><td char="." align="char">3</td><td align="left">&#x02013;</td><td align="left">6%</td><td align="left">2&#x02013;9%</td></tr><tr><td align="left" colspan="5">&#x000a0;Functional outcome</td></tr><tr><td align="left">&#x000a0;Zubrod scores at 12&#x000a0;months</td><td char="." align="char">7</td><td align="left">&#x02013;</td><td align="left">3.5</td><td align="left">3.2&#x02013;3.5</td></tr><tr><td align="left">&#x000a0;EQ-5D utility at 12&#x000a0;months</td><td char="." align="char">2</td><td align="left">&#x02013;</td><td align="left">0.71</td><td align="left">0.55&#x02013;0.86</td></tr><tr><td align="left">&#x000a0;S&#x000a0;BBP scores at 12&#x000a0;months</td><td char="." align="char">3</td><td align="left">&#x02013;</td><td align="left">5.0</td><td align="left">3.1&#x02013;5.3</td></tr><tr><td align="left" colspan="5">Persistent critical illness (PerCI)</td></tr><tr><td align="left">&#x000a0;In-hospital mortality</td><td char="." align="char">12</td><td align="left">26% (24&#x02013;29%)</td><td align="left">&#x02013;</td><td align="left">8&#x02013;45%</td></tr><tr><td align="left">&#x000a0;Median length of ICU, days</td><td char="." align="char">15</td><td align="left">&#x02013;</td><td align="left">17</td><td align="left">4&#x02013;28</td></tr><tr><td align="left">&#x000a0;Median length of stay, days</td><td char="." align="char">3</td><td align="left">&#x02013;</td><td align="left">28</td><td align="left">25&#x02013;32</td></tr><tr><td align="left">&#x000a0;Median length of MV, days</td><td char="." align="char">2</td><td align="left">&#x02013;</td><td align="left">17.5</td><td align="left">16&#x02013;19</td></tr><tr><td align="left" colspan="5">&#x000a0;Discharge destinations</td></tr><tr><td align="left"> Home</td><td char="." align="char">3</td><td align="left">&#x02013;</td><td align="left">43%</td><td align="left">18&#x02013;47%</td></tr><tr><td align="left"> Another hospital</td><td char="." align="char">2</td><td align="left">&#x02013;</td><td align="left">19.5%</td><td align="left">8&#x02013;31%</td></tr><tr><td align="left"> Rehabilitation facilities</td><td char="." align="char">3</td><td align="left">&#x02013;</td><td align="left">12%</td><td align="left">11&#x02013;38%</td></tr></tbody></table><table-wrap-foot><p><italic>PerCI</italic> persistent critical illness; <italic>CCI</italic> chronic critical illness; <italic>CI</italic> confidence intervals; <italic>ICU</italic> intensive care unit; <italic>MV</italic> mechanical ventilation; <italic>EQ-5D</italic> EuroQol five-dimensional; <italic>SPPB</italic> Short Physical Performance Battery</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Meta-analysis for in-hospital mortality of PerCI/CCI. The summary statistics (diamonds) for each stratum and all studies overall are the results of a random effects model. <italic>PerCI</italic> persistent critical illness; <italic>CCI</italic> chronic critical illness</p></caption><graphic xlink:href="13054_2024_5215_Fig3_HTML" id="MO3"/></fig></p><p id="Par32">The median of median durations of ICU stay, hospital stay, and MV were 21, 43, and 20&#x000a0;days, respectively (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The median percentages of median home discharge, transfers to another hospital, rehabilitation facilities, nursing facilities, and hospice were 24, 16, 26, 16, and 6%, respectively (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and Supplemental Table&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>).</p><p id="Par33">Functional outcomes reported across various studies indicated that the mean Zubrod Performance Score at 12&#x000a0;months was consistently between 3.2 and 3.5, reflecting patients capable of only limited self-care and confined to bed or a chair 50% or more of waking hours (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and Supplemental Table&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>). Other metrics, such as the Short Physical Performance Battery score, ranged between 3.1 and 5.3, and EuroQol five-dimensional utility scores at 12&#x000a0;months ranged between 0.55 and 0.86, highlighting worsened levels of physical performance and quality of life.</p></sec></sec><sec id="Sec15"><title>Discussion</title><p id="Par34">This review underscores the variability in definitions and terminologies used to describe PerCI/CCI across studies. Over the past decade, the terms CCI and PerCI have become more widely accepted and utilized, rather than &#x0201c;chronic critically ill&#x0201d;, &#x0201c;prolonged critical illness&#x0201d;, and &#x0201c;chronically critically ill&#x0201d;. While CCI shows significant variability in its definition, the definition of PerCI has remained relatively consistent. CCI and PerCI both focus primarily on the duration of the ICU stay, with critical time points often differing only slightly, such as 10 or 14&#x000a0;days. In addition, this review found no clinically meaningful differences in prevalence and mortality between patients with CCI and PerCI. Given that recent increasing trend and relatively uniform definition of PerCI, it may be worth considering standardizing the use of the term PerCI for these conditions to enhance comparability across studies and improve the consistency in research and care strategies and [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par35">Although PerCI/CCI requires standardization, PICS and PIICS serve distinct purposes from PerCI/CCI. PICS focuses on the long-term sequelae of ICU survivors, encompassing physical, mental, and cognitive impairments to drive interventions that minimize these disabilities [<xref ref-type="bibr" rid="CR9">9</xref>]. PIICS targets persistent inflammation, immunosuppression, and catabolism to identify the underlying mechanisms and select appropriate therapeutic interventions [<xref ref-type="bibr" rid="CR3">3</xref>]. While the use of these terms needs to continue where appropriate, further research is needed to explore whether the clinical and metabolic definitions overlap.</p><p id="Par36">In this review approximately 10% of all ICU patients developed PerCI/CCI and its prevalence was even higher in severe acute illnesses, including sepsis (28%), trauma (24%), and COVID-19 (35%). Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> provides a comprehensive overview of the results obtained in this review. Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> may be also used to improve healthcare providers&#x02019; awareness and understanding of these conditions and as well as to facilitate effective communication with patients and their families. We identified higher severity of illness as a risk factor for PerCI/CCI, while previous studies reported that patients with sepsis [<xref ref-type="bibr" rid="CR119">119</xref>], trauma [<xref ref-type="bibr" rid="CR120">120</xref>], and COVID-19 [<xref ref-type="bibr" rid="CR121">121</xref>] had higher severity of illness than all patients admitted to the ICU. Another reason may be severe inflammation and the high prevalence of PIICS in these diseases, which are associated with PerCI/CCI [<xref ref-type="bibr" rid="CR3">3</xref>]. Recognizing the high-risk disease categories for developing PerCI/CCI, such as sepsis and trauma, can enhance the quality of clinical research on these conditions as well as allow for better information sharing with patients and their families at the time of ICU admission.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Infographic of a comprehensive summary of this review for translation to clinical practice. CI, confidence interval; ICU, intensive care unit; COVID-19, corona virus infection disease 2019; <italic>PerCI</italic> persistent critical illness; <italic>CCI</italic> chronic critical illness; <italic>MV</italic> mechanical ventilation</p></caption><graphic xlink:href="13054_2024_5215_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Layperson-friendly infographic of this review for patients with PerCI/CCI and their families. <italic>PerCI</italic> persistent critical illness; <italic>CCI</italic> chronic critical illness; <italic>ICU</italic> intensive care unit</p></caption><graphic xlink:href="13054_2024_5215_Fig5_HTML" id="MO5"/></fig></p><p id="Par37">A recent systematic review on PIICS identified similar risk factors to those in the present study, including an older age, more severe illness, and increased comorbidities [<xref ref-type="bibr" rid="CR3">3</xref>]. These findings suggest an overlap with PIICS for PerCI/CCI, emphasizing shared pathophysiological mechanisms. However, the relationship between PIICS and PerCI/CCI remains unclear, raising questions such as whether PIICS is a consequence of ongoing organ dysfunction in PerCI/CCI, whether PIICS is a pathophysiological mechanism of PerCI/CCI, or whether PIICS is an endotype of PerCI/CCI [<xref ref-type="bibr" rid="CR3">3</xref>]. Therefore, further research is needed to elucidate these complex relationships.</p><p id="Par38">Over the past two decades, the accumulation of knowledge on PerCI/CCI patients and their families has led to the present review results. The results obtained herein indicate that 25% of PerCI/CCI patients died in-hospital and more than 50% of PerCI/CCI survivors required long-term care hospitals or skilled nursing homes, with a very high one-year mortality rate of 45%. These patients commonly had impaired functional capacity in their activities of daily living and often become significantly dependent on others at 12 months after ICU admission. Providing adequate information on the possibility of these impairments in layperson-friendly terms is essential for effective communication with patients and their families and for reaching the correct consensus [<xref ref-type="bibr" rid="CR122">122</xref>&#x02013;<xref ref-type="bibr" rid="CR124">124</xref>].</p><p id="Par39">Identifying patients at risk of PerCI/CCI and clarifying their life and functional prognosis may aid in providing appropriate end-of-life care. Camhi et al. found that only 21% of CCI patients had appointed a healthcare proxy, and 16% had expressed treatment preferences through advance directives [<xref ref-type="bibr" rid="CR117">117</xref>]. Given the severity and long-term nature of brain dysfunction in patients with CCI [<xref ref-type="bibr" rid="CR125">125</xref>], difficulties are associated with achieving the goals of care conversions, including the withdrawal of life-supporting treatment. It has also been pointed out that older ICU survivors, including PerCI/CCI patients, may have unmet palliative care needs [<xref ref-type="bibr" rid="CR22">22</xref>]. While the present study identified risk factors for PerCI/CCI, such as an advanced age, high severity, and the need for organ support, studies on this topic remain scattered and insufficient at present.</p><sec id="Sec16"><title>Future perspectives</title><p id="Par40">Future research needs to focus on the standardization of definitions for PerCI/CCI, which will enhance the comparability of studies and contribute to more consistent care pathways. Additionally, more studies are needed to examine the long-term outcomes of patients with PerCI/CCI, including functional outcomes and quality of life. The impact of providing prognostic information to clinicians as well as patients and families with PerCI/CCI, including the results of this scoping review, will also need to be investigated. PerCI/CCI is still a new disease concept and will need to be systematically reviewed again in the future.</p></sec><sec id="Sec17"><title>Strengths and limitations</title><p id="Par41">This review&#x02019;s strength lies in its systematic approach, which enabled the comprehensive identification and analysis of a wide range of original articles. Despite its strengths, this scoping review has some limitations. To make our review more feasible, we were only able to include 5 terms for PerCI/CCI. Therefore, it is possible that terms other than the five listed above or studies that did not use these terms, but examined PerCI/CCI were not included. Furthermore, there was large heterogeneity in the quality, definitions, and populations of the studies reviewed, which may have affected the generalizability of the results obtained. In addition, there may have been a publication bias, with more severe cases or better performing facilities more likely to be reported. Moreover, this review focused on adults because children with PerCI/CCI have significantly different definitions, characteristics, recovery patterns, and treatment approaches [<xref ref-type="bibr" rid="CR126">126</xref>]. Therefore, the present results cannot be generalized to the pediatric population. Another limitation is the lack of a description of long-COVID in the study on COVID. Further studies are needed to investigate how long-COVID symptoms relate to PerCI/CCI and PICS. Moreover, since this study used a scoping review methodology, the data charting process may be arbitrary by the reviewer.</p></sec></sec><sec id="Sec18"><title>Conclusion</title><p id="Par42">This scoping review synthesized a wide range of studies on PerCI/CCI, highlighting the serious impact of PerCI/CCI on patients&#x02019; long-term outcomes. The present results underscore the need for consistent terminology with high-quality research to further elucidate risk factors and improve patient care. The results obtained provide important information to be used in discussions with patients and families regarding the definitions, prevalence, risk factors, and outcomes associated with these conditions. However, there is still need for higher quality original research studies using consistent terminology with long term follow-up data.</p></sec><sec id="Sec19" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13054_2024_5215_MOESM1_ESM.pdf"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13054_2024_5215_MOESM2_ESM.docx"><caption><p>Supplementary Material 2.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13054_2024_5215_MOESM3_ESM.pdf"><caption><p>Supplementary Material 3.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ICU</term><def><p id="Par6">Intensive care unit</p></def></def-item><def-item><term>PerCI</term><def><p id="Par7">Persistent critical illness</p></def></def-item><def-item><term>CCI</term><def><p id="Par8">Chronic critical illness</p></def></def-item><def-item><term>PICS</term><def><p id="Par9">Post-intensive care syndrome</p></def></def-item><def-item><term>PIICS</term><def><p id="Par10">Persistent inflammatory, immunosuppressive, and catabolic syndrome</p></def></def-item><def-item><term>PRISMA-ScR</term><def><p id="Par11">Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews</p></def></def-item><def-item><term>APACHE</term><def><p id="Par12">Acute physiology and chronic health evaluation</p></def></def-item><def-item><term>IQR</term><def><p id="Par13">Interquartile range</p></def></def-item><def-item><term>MV</term><def><p id="Par14">Mechanical ventilation</p></def></def-item><def-item><term>COVID-19</term><def><p id="Par15">Corona virus disease 2019</p></def></def-item><def-item><term>CI</term><def><p id="Par16">Confidence interval</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to thank the J-STAD (JAPAN Sepsis Treatment and Diagnosis) Study Group for their support and contribution to this work. The following are members of the J-STAD Study Group other than the listed authors: Takayuki Ogura, Yu Kawazoe, Gaku Takahashi, Takashi Tagami, Chie Tanaka, Akihito Tampo, Kota Hoshino, and Katsunori Mochizuki.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>HO designed the review and wrote the initial drafts of the manuscript. KN contributed to the study conception and critically revised the manuscript. All other authors contributed substantially to the conception and design of the work, the acquisition and interpretation of the literature review, and the drafting and revision of the manuscript. All the authors have read and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par43">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par44">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par45">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Daniela</surname><given-names>L</given-names></name></person-group><article-title>Chronic critical illness</article-title><source>N Engl J Med</source><year>2014</year><volume>370</volume><issue>2</issue><fpage>175</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1056/NEJMms1310675</pub-id><pub-id pub-id-type="pmid">24401058</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Daniela L. Chronic critical illness. N Engl J Med. 2014;370(2):175&#x02013;7.<pub-id pub-id-type="pmid">24401058</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JE</given-names></name><name><surname>Cox</surname><given-names>CE</given-names></name><name><surname>Hope</surname><given-names>AA</given-names></name><name><surname>Carson</surname><given-names>SS</given-names></name></person-group><article-title>Chronic critical illness</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><issue>4</issue><fpage>446</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1164/rccm.201002-0210CI</pub-id><pub-id pub-id-type="pmid">20448093</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med. 2010;182(4):446&#x02013;54.<pub-id pub-id-type="pmid">20448093</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Chadda</surname><given-names>KR</given-names></name><name><surname>Puthucheary</surname><given-names>Z</given-names></name></person-group><article-title>Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities</article-title><source>Br J Anaesth</source><year>2024</year><volume>132</volume><issue>3</issue><fpage>507</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2023.11.052</pub-id><pub-id pub-id-type="pmid">38177003</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Chadda KR, Puthucheary Z. Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities. Br J Anaesth. 2024;132(3):507&#x02013;18.<pub-id pub-id-type="pmid">38177003</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Zilberberg</surname><given-names>MD</given-names></name><name><surname>de Wit</surname><given-names>M</given-names></name><name><surname>Pirone</surname><given-names>JR</given-names></name><name><surname>Shorr</surname><given-names>AF</given-names></name></person-group><article-title>Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><issue>5</issue><fpage>1451</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3181691a49</pub-id><pub-id pub-id-type="pmid">18434911</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Zilberberg MD, de Wit M, Pirone JR, Shorr AF. Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery. Crit Care Med. 2008;36(5):1451&#x02013;5.<pub-id pub-id-type="pmid">18434911</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Sjoding</surname><given-names>MW</given-names></name><name><surname>Cooke</surname><given-names>CR</given-names></name></person-group><article-title>Chronic critical illness: a growing legacy of successful advances in critical care</article-title><source>Crit Care Med</source><year>2015</year><volume>43</volume><issue>2</issue><fpage>476</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000000780</pub-id><pub-id pub-id-type="pmid">25599471</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Sjoding MW, Cooke CR. Chronic critical illness: a growing legacy of successful advances in critical care. Crit Care Med. 2015;43(2):476&#x02013;7.<pub-id pub-id-type="pmid">25599471</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>MD</given-names></name><name><surname>Vanzant</surname><given-names>EL</given-names></name><name><surname>Moore</surname><given-names>FA</given-names></name></person-group><article-title>Chronic critical illness and PICS nutritional strategies</article-title><source>J Clin Med Res</source><year>2021</year><volume>10</volume><issue>11</issue><fpage>2294</fpage><pub-id pub-id-type="doi">10.3390/jcm10112294</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Rosenthal MD, Vanzant EL, Moore FA. Chronic critical illness and PICS nutritional strategies. J Clin Med Res. 2021;10(11):2294. 10.3390/jcm10112294.</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>AF</given-names></name><name><surname>Prescott</surname><given-names>HC</given-names></name><name><surname>Brett</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Long-term outcomes after critical illness: recent insights</article-title><source>Crit Care</source><year>2021</year><volume>25</volume><issue>1</issue><fpage>108</fpage><pub-id pub-id-type="doi">10.1186/s13054-021-03535-3</pub-id><pub-id pub-id-type="pmid">33731201</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Rousseau AF, Prescott HC, Brett SJ, et al. Long-term outcomes after critical illness: recent insights. Crit Care. 2021;25(1):108.<pub-id pub-id-type="pmid">33731201</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>RB</given-names></name><name><surname>Raymond</surname><given-names>SL</given-names></name><name><surname>Stortz</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>1511</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.01511</pub-id><pub-id pub-id-type="pmid">30013565</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Hawkins RB, Raymond SL, Stortz JA, et al. Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome. Front Immunol. 2018;9:1511.<pub-id pub-id-type="pmid">30013565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Voiriot</surname><given-names>G</given-names></name><name><surname>Oualha</surname><given-names>M</given-names></name><name><surname>Pierre</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges</article-title><source>Ann Intensive Care</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s13613-022-01038-0</pub-id><pub-id pub-id-type="pmid">35779142</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Voiriot G, Oualha M, Pierre A, et al. Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges. Ann Intensive Care. 2022;12(1):58.<pub-id pub-id-type="pmid">35779142</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Wiencek</surname><given-names>C</given-names></name><name><surname>Winkelman</surname><given-names>C</given-names></name></person-group><article-title>Chronic critical illness: prevalence, profile, and pathophysiology</article-title><source>AACN Adv Crit Care</source><year>2010</year><volume>21</volume><issue>1</issue><fpage>44</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">20118704</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Wiencek C, Winkelman C. Chronic critical illness: prevalence, profile, and pathophysiology. AACN Adv Crit Care. 2010;21(1):44&#x02013;61.<pub-id pub-id-type="pmid">20118704</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Madrid</surname><given-names>RA</given-names></name><name><surname>McGee</surname><given-names>W</given-names></name></person-group><article-title>Value, chronic critical illness, and choosing wisely</article-title><source>J Intensive Care Med</source><year>2019</year><volume>34</volume><issue>8</issue><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1177/0885066618790942</pub-id><pub-id pub-id-type="pmid">30064283</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Madrid RA, McGee W. Value, chronic critical illness, and choosing wisely. J Intensive Care Med. 2019;34(8):609&#x02013;14.<pub-id pub-id-type="pmid">30064283</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Marchioni</surname><given-names>A</given-names></name><name><surname>Fantini</surname><given-names>R</given-names></name><name><surname>Antenora</surname><given-names>F</given-names></name><name><surname>Clini</surname><given-names>E</given-names></name><name><surname>Fabbri</surname><given-names>L</given-names></name></person-group><article-title>Chronic critical illness: the price of survival</article-title><source>Eur J Clin Invest</source><year>2015</year><volume>45</volume><issue>12</issue><fpage>1341</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1111/eci.12547</pub-id><pub-id pub-id-type="pmid">26549412</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Marchioni A, Fantini R, Antenora F, Clini E, Fabbri L. Chronic critical illness: the price of survival. Eur J Clin Invest. 2015;45(12):1341&#x02013;9.<pub-id pub-id-type="pmid">26549412</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>MD</given-names></name><name><surname>Kamel</surname><given-names>AY</given-names></name><name><surname>Rosenthal</surname><given-names>CM</given-names></name><name><surname>Brakenridge</surname><given-names>S</given-names></name><name><surname>Croft</surname><given-names>CA</given-names></name><name><surname>Moore</surname><given-names>FA</given-names></name></person-group><article-title>Chronic critical illness: application of what we know</article-title><source>Nutr Clin Pract</source><year>2018</year><volume>33</volume><issue>1</issue><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1002/ncp.10024</pub-id><pub-id pub-id-type="pmid">29323761</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Rosenthal MD, Kamel AY, Rosenthal CM, Brakenridge S, Croft CA, Moore FA. Chronic critical illness: application of what we know. Nutr Clin Pract. 2018;33(1):39&#x02013;45.<pub-id pub-id-type="pmid">29323761</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Tricco</surname><given-names>AC</given-names></name><name><surname>Lillie</surname><given-names>E</given-names></name><name><surname>Zarin</surname><given-names>W</given-names></name><etal/></person-group><article-title>PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation</article-title><source>Ann Intern Med</source><year>2018</year><volume>169</volume><issue>7</issue><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467&#x02013;73.<pub-id pub-id-type="pmid">30178033</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Ouzzani</surname><given-names>M</given-names></name><name><surname>Hammady</surname><given-names>H</given-names></name><name><surname>Fedorowicz</surname><given-names>Z</given-names></name><name><surname>Elmagarmid</surname><given-names>A</given-names></name></person-group><article-title>Rayyan-a web and mobile app for systematic reviews</article-title><source>Syst Rev</source><year>2016</year><volume>5</volume><issue>1</issue><fpage>210</fpage><pub-id pub-id-type="doi">10.1186/s13643-016-0384-4</pub-id><pub-id pub-id-type="pmid">27919275</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.<pub-id pub-id-type="pmid">27919275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzen</surname><given-names>SA</given-names></name><name><surname>Dani&#x000eb;ls</surname><given-names>R</given-names></name><name><surname>van Bokhoven</surname><given-names>MA</given-names></name><name><surname>van der Weijden</surname><given-names>T</given-names></name><name><surname>Beurskens</surname><given-names>A</given-names></name></person-group><article-title>Disentangling self-management goal setting and action planning: a scoping review</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>11</issue><fpage>e0188822</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0188822</pub-id><pub-id pub-id-type="pmid">29176800</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Lenzen SA, Dani&#x000eb;ls R, van Bokhoven MA, van der Weijden T, Beurskens A. Disentangling self-management goal setting and action planning: a scoping review. PLoS ONE. 2017;12(11):e0188822.<pub-id pub-id-type="pmid">29176800</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Nyaga</surname><given-names>VN</given-names></name><name><surname>Arbyn</surname><given-names>M</given-names></name><name><surname>Aerts</surname><given-names>M</given-names></name></person-group><article-title>Metaprop: a Stata command to perform meta-analysis of binomial data</article-title><source>Arch Public Health</source><year>2014</year><volume>72</volume><issue>1</issue><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/2049-3258-72-39</pub-id><pub-id pub-id-type="pmid">25810908</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39.<pub-id pub-id-type="pmid">25810908</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Fisher D, Harris R, Bradburn M, et al. METAN: Stata module for fixed and random effects meta-analysis. <italic>Statistical Software Components</italic>. S456798, Boston College Department of Economics, revised 15 Jul 2024.</mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Julian PT Higgins, Tianjing Li, Jonathan J Deeks. Chapter 6: Choosing effect measures and computing estimates of effect. <italic>Cochrane Handbook for Systematic Reviews of Interventions</italic> version 6.5. Cochrane, 2024. Available from <ext-link ext-link-type="uri" xlink:href="http://www.training.cochrane.org/handbook">www.training.cochrane.org/handbook</ext-link>.</mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JE</given-names></name><name><surname>Meier</surname><given-names>DE</given-names></name><name><surname>Litke</surname><given-names>A</given-names></name><name><surname>Natale</surname><given-names>DA</given-names></name><name><surname>Siegel</surname><given-names>RE</given-names></name><name><surname>Morrison</surname><given-names>RS</given-names></name></person-group><article-title>The symptom burden of chronic critical illness</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><issue>7</issue><fpage>1527</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000129485.08835.5A</pub-id><pub-id pub-id-type="pmid">15241097</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Nelson JE, Meier DE, Litke A, Natale DA, Siegel RE, Morrison RS. The symptom burden of chronic critical illness. Crit Care Med. 2004;32(7):1527&#x02013;34.<pub-id pub-id-type="pmid">15241097</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Via</surname><given-names>MA</given-names></name><name><surname>Potenza</surname><given-names>MV</given-names></name><name><surname>Hollander</surname><given-names>J</given-names></name><etal/></person-group><article-title>Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness</article-title><source>J Intensive Care Med</source><year>2012</year><volume>27</volume><issue>5</issue><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1177/0885066611402156</pub-id><pub-id pub-id-type="pmid">21436164</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Via MA, Potenza MV, Hollander J, et al. Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness. J Intensive Care Med. 2012;27(5):312&#x02013;8.<pub-id pub-id-type="pmid">21436164</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>MR</given-names></name><name><surname>Wunsch</surname><given-names>H</given-names></name><name><surname>Reyfman</surname><given-names>PA</given-names></name><etal/></person-group><article-title>High burden of palliative needs among older intensive care unit survivors transferred to post-acute care facilities. A single-center study</article-title><source>Ann Am Thorac Soc</source><year>2013</year><volume>10</volume><issue>5</issue><fpage>458</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.201303-039OC</pub-id><pub-id pub-id-type="pmid">23987743</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Baldwin MR, Wunsch H, Reyfman PA, et al. High burden of palliative needs among older intensive care unit survivors transferred to post-acute care facilities. A single-center study. Ann Am Thorac Soc. 2013;10(5):458&#x02013;65.<pub-id pub-id-type="pmid">23987743</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>JM</given-names></name><name><surname>Werner</surname><given-names>RM</given-names></name><name><surname>David</surname><given-names>G</given-names></name><name><surname>Ten Have</surname><given-names>TR</given-names></name><name><surname>Benson</surname><given-names>NM</given-names></name><name><surname>Asch</surname><given-names>DA</given-names></name></person-group><article-title>Effectiveness of long-term acute care hospitalization in elderly patients with chronic critical illness</article-title><source>Med Care</source><year>2013</year><volume>51</volume><issue>1</issue><fpage>4</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1097/MLR.0b013e31826528a7</pub-id><pub-id pub-id-type="pmid">22874500</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kahn JM, Werner RM, David G, Ten Have TR, Benson NM, Asch DA. Effectiveness of long-term acute care hospitalization in elderly patients with chronic critical illness. Med Care. 2013;51(1):4&#x02013;10.<pub-id pub-id-type="pmid">22874500</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Loss</surname><given-names>SH</given-names></name><name><surname>Marchese</surname><given-names>CB</given-names></name><name><surname>Boniatti</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Prediction of chronic critical illness in a general intensive care unit</article-title><source>Rev Assoc Med Bras</source><year>2013</year><volume>59</volume><issue>3</issue><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.ramb.2012.12.002</pub-id><pub-id pub-id-type="pmid">23680275</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Loss SH, Marchese CB, Boniatti MM, et al. Prediction of chronic critical illness in a general intensive care unit. Rev Assoc Med Bras. 2013;59(3):241&#x02013;7.<pub-id pub-id-type="pmid">23680275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>JM</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name><etal/></person-group><article-title>The epidemiology of chronic critical illness in the United States*</article-title><source>Crit Care Med</source><year>2015</year><volume>43</volume><issue>2</issue><fpage>282</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000000710</pub-id><pub-id pub-id-type="pmid">25377018</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Kahn JM, Le T, Angus DC, et al. The epidemiology of chronic critical illness in the United States*. Crit Care Med. 2015;43(2):282&#x02013;7.<pub-id pub-id-type="pmid">25377018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>SS</given-names></name><name><surname>Cox</surname><given-names>CE</given-names></name><name><surname>Wallenstein</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial</article-title><source>JAMA</source><year>2016</year><volume>316</volume><issue>1</issue><fpage>51</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.8474</pub-id><pub-id pub-id-type="pmid">27380343</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Carson SS, Cox CE, Wallenstein S, et al. Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA. 2016;316(1):51&#x02013;62.<pub-id pub-id-type="pmid">27380343</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Mira</surname><given-names>JC</given-names></name><name><surname>Cuschieri</surname><given-names>J</given-names></name><name><surname>Ozrazgat-Baslanti</surname><given-names>T</given-names></name><etal/></person-group><article-title>The epidemiology of chronic critical illness after severe traumatic injury at two level-one trauma centers</article-title><source>Crit Care Med</source><year>2017</year><volume>45</volume><issue>12</issue><fpage>1989</fpage><lpage>1996</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000002697</pub-id><pub-id pub-id-type="pmid">28837430</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Mira JC, Cuschieri J, Ozrazgat-Baslanti T, et al. The epidemiology of chronic critical illness after severe traumatic injury at two level-one trauma centers. Crit Care Med. 2017;45(12):1989&#x02013;96.<pub-id pub-id-type="pmid">28837430</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name><name><surname>Stortz</surname><given-names>JA</given-names></name><etal/></person-group><article-title>The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients</article-title><source>J Trauma Acute Care Surg</source><year>2018</year><volume>85</volume><issue>2</issue><fpage>247</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1097/TA.0000000000001921</pub-id><pub-id pub-id-type="pmid">29613958</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Brakenridge SC, Efron PA, Stortz JA, et al. The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients. J Trauma Acute Care Surg. 2018;85(2):247&#x02013;55.<pub-id pub-id-type="pmid">29613958</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Davoudi</surname><given-names>A</given-names></name><name><surname>Corbett</surname><given-names>DB</given-names></name><name><surname>Ozrazgat-Baslanti</surname><given-names>T</given-names></name><etal/></person-group><article-title>Activity and circadian rhythm of sepsis patients in the Intensive Care Unit</article-title><source>IEEE EMBS Int Conf Biomed Health Inform</source><year>2018</year><volume>2018</volume><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">30411088</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Davoudi A, Corbett DB, Ozrazgat-Baslanti T, et al. Activity and circadian rhythm of sepsis patients in the Intensive Care Unit. IEEE EMBS Int Conf Biomed Health Inform. 2018;2018:17&#x02013;20.<pub-id pub-id-type="pmid">30411088</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Stortz</surname><given-names>JA</given-names></name><name><surname>Murphy</surname><given-names>TJ</given-names></name><name><surname>Raymond</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis</article-title><source>Shock</source><year>2018</year><volume>49</volume><issue>3</issue><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1097/SHK.0000000000000981</pub-id><pub-id pub-id-type="pmid">28885387</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Stortz JA, Murphy TJ, Raymond SL, et al. Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis. Shock. 2018;49(3):249&#x02013;58.<pub-id pub-id-type="pmid">28885387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Stortz</surname><given-names>JA</given-names></name><name><surname>Mira</surname><given-names>JC</given-names></name><name><surname>Raymond</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients</article-title><source>J Trauma Acute Care Surg</source><year>2018</year><volume>84</volume><issue>2</issue><fpage>342</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1097/TA.0000000000001758</pub-id><pub-id pub-id-type="pmid">29251709</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Stortz JA, Mira JC, Raymond SL, et al. Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients. J Trauma Acute Care Surg. 2018;84(2):342&#x02013;9.<pub-id pub-id-type="pmid">29251709</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Mehrholz</surname><given-names>J</given-names></name></person-group><article-title>Health-related quality of life, participation, and physical and cognitive function of patients with intensive care unit-acquired muscle weakness 1 year after rehabilitation in Germany: the GymNAST cohort study</article-title><source>BMJ Open</source><year>2018</year><volume>8</volume><issue>7</issue><fpage>e020163</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2017-020163</pub-id><pub-id pub-id-type="pmid">30007926</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Thomas S, Mehrholz J. Health-related quality of life, participation, and physical and cognitive function of patients with intensive care unit-acquired muscle weakness 1 year after rehabilitation in Germany: the GymNAST cohort study. BMJ Open. 2018;8(7):e020163.<pub-id pub-id-type="pmid">30007926</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Aguiar</surname><given-names>FP</given-names></name><name><surname>Westphal</surname><given-names>GA</given-names></name><name><surname>Dadam</surname><given-names>MM</given-names></name><name><surname>Mota</surname><given-names>ECC</given-names></name><name><surname>Pfutzenreuter</surname><given-names>F</given-names></name><name><surname>Fran&#x000e7;a</surname><given-names>PHC</given-names></name></person-group><article-title>Characteristics and predictors of chronic critical illness in the intensive care unit</article-title><source>Rev Bras Ter Intensiva</source><year>2019</year><volume>31</volume><issue>4</issue><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.5935/0103-507X.20190088</pub-id><pub-id pub-id-type="pmid">31967226</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Aguiar FP, Westphal GA, Dadam MM, Mota ECC, Pfutzenreuter F, Fran&#x000e7;a PHC. Characteristics and predictors of chronic critical illness in the intensive care unit. Rev Bras Ter Intensiva. 2019;31(4):511&#x02013;20.<pub-id pub-id-type="pmid">31967226</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Moore</surname><given-names>FA</given-names></name><name><surname>Mercier</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Persistently elevated glucagon-like peptide-1 levels among critically ill surgical patients after sepsis and development of chronic critical illness and dismal long-term outcomes</article-title><source>J Am Coll Surg</source><year>2019</year><volume>229</volume><issue>1</issue><fpage>58</fpage><lpage>67.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2019.04.014</pub-id><pub-id pub-id-type="pmid">30991107</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Brakenridge SC, Moore FA, Mercier NR, et al. Persistently elevated glucagon-like peptide-1 levels among critically ill surgical patients after sepsis and development of chronic critical illness and dismal long-term outcomes. J Am Coll Surg. 2019;229(1):58-67.e1.<pub-id pub-id-type="pmid">30991107</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name><name><surname>Cox</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Current epidemiology of surgical sepsis: discordance between inpatient mortality and 1-year outcomes</article-title><source>Ann Surg</source><year>2019</year><volume>270</volume><issue>3</issue><fpage>502</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000003458</pub-id><pub-id pub-id-type="pmid">31356275</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Brakenridge SC, Efron PA, Cox MC, et al. Current epidemiology of surgical sepsis: discordance between inpatient mortality and 1-year outcomes. Ann Surg. 2019;270(3):502&#x02013;10.<pub-id pub-id-type="pmid">31356275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Custodero</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Ghita</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Prognostic value of NT-proBNP levels in the acute phase of sepsis on lower long-term physical function and muscle strength in sepsis survivors</article-title><source>Crit Care</source><year>2019</year><volume>23</volume><issue>1</issue><fpage>230</fpage><pub-id pub-id-type="doi">10.1186/s13054-019-2505-7</pub-id><pub-id pub-id-type="pmid">31234943</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Custodero C, Wu Q, Ghita GL, et al. Prognostic value of NT-proBNP levels in the acute phase of sepsis on lower long-term physical function and muscle strength in sepsis survivors. Crit Care. 2019;23(1):230.<pub-id pub-id-type="pmid">31234943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>AK</given-names></name><name><surname>Ghita</surname><given-names>GL</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs</article-title><source>Crit Care Med</source><year>2019</year><volume>47</volume><issue>4</issue><fpage>566</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000003655</pub-id><pub-id pub-id-type="pmid">30664526</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gardner AK, Ghita GL, Wang Z, et al. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs. Crit Care Med. 2019;47(4):566&#x02013;73.<pub-id pub-id-type="pmid">30664526</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Mehrholz</surname><given-names>J</given-names></name><name><surname>Bodechtel</surname><given-names>U</given-names></name><name><surname>Elsner</surname><given-names>B</given-names></name></person-group><article-title>Effect of physiotherapy on regaining independent walking in patients with intensive-care-unit-acquired muscle weakness: a cohort study</article-title><source>J Rehabil Med</source><year>2019</year><volume>51</volume><issue>10</issue><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.2340/16501977-2606</pub-id><pub-id pub-id-type="pmid">31544216</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Thomas S, Mehrholz J, Bodechtel U, Elsner B. Effect of physiotherapy on regaining independent walking in patients with intensive-care-unit-acquired muscle weakness: a cohort study. J Rehabil Med. 2019;51(10):797&#x02013;804.<pub-id pub-id-type="pmid">31544216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>MV</given-names></name><name><surname>Pantet</surname><given-names>O</given-names></name><name><surname>Bagnoud</surname><given-names>G</given-names></name><etal/></person-group><article-title>Metabolic and nutritional characteristics of long-stay critically ill patients</article-title><source>J Clin Med Res</source><year>2019</year><volume>8</volume><issue>7</issue><fpage>985</fpage></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Viana MV, Pantet O, Bagnoud G, et al. Metabolic and nutritional characteristics of long-stay critically ill patients. J Clin Med Res. 2019;8(7):985.</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Bento Talizin</surname><given-names>T</given-names></name><name><surname>de Dantas Maio Carriho</surname><given-names>CM</given-names></name><name><surname>Magalh&#x000e3;es Carvalho Grion</surname><given-names>C</given-names></name><etal/></person-group><article-title>Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><issue>8</issue><fpage>e0237880</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0237880</pub-id><pub-id pub-id-type="pmid">32813749</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Bento Talizin T, de Dantas Maio Carriho CM, Magalh&#x000e3;es Carvalho Grion C, et al. Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance. PLoS ONE. 2020;15(8):e0237880.<pub-id pub-id-type="pmid">32813749</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>MC</given-names></name><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Stortz</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomes</article-title><source>Am J Surg</source><year>2020</year><volume>220</volume><issue>6</issue><fpage>1467</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2020.07.016</pub-id><pub-id pub-id-type="pmid">32807383</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Cox MC, Brakenridge SC, Stortz JA, et al. Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomes. Am J Surg. 2020;220(6):1467&#x02013;74.<pub-id pub-id-type="pmid">32807383</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Demirkiran</surname><given-names>H</given-names></name><name><surname>Uzunoglu</surname><given-names>E</given-names></name><name><surname>Erdivanli</surname><given-names>B</given-names></name><etal/></person-group><article-title>Prevalence and clinical features of chronic critical illness in the elderly population in Turkey</article-title><source>Turk Geriatri Derg</source><year>2020</year><volume>23</volume><issue>4</issue><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.31086/tjgeri.2020.188</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Demirkiran H, Uzunoglu E, Erdivanli B, et al. Prevalence and clinical features of chronic critical illness in the elderly population in Turkey. Turk Geriatri Derg. 2020;23(4):501&#x02013;8.</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>RB</given-names></name><name><surname>Stortz</surname><given-names>JA</given-names></name><name><surname>Holden</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Persistently increased cell-free DNA concentrations only modestly contribute to outcome and host response in sepsis survivors with chronic critical illness</article-title><source>Surgery</source><year>2020</year><volume>167</volume><issue>3</issue><fpage>646</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2019.11.018</pub-id><pub-id pub-id-type="pmid">31898953</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Hawkins RB, Stortz JA, Holden DC, et al. Persistently increased cell-free DNA concentrations only modestly contribute to outcome and host response in sepsis survivors with chronic critical illness. Surgery. 2020;167(3):646&#x02013;52.<pub-id pub-id-type="pmid">31898953</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Hesselink</surname><given-names>L</given-names></name><name><surname>Hoepelman</surname><given-names>RJ</given-names></name><name><surname>Spijkerman</surname><given-names>R</given-names></name><etal/></person-group><article-title>Persistent inflammation, immunosuppression and catabolism syndrome (PICS) after polytrauma: A rare syndrome with major consequences</article-title><source>J Clin Med Res</source><year>2020</year><volume>9</volume><issue>1</issue><fpage>191</fpage></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Hesselink L, Hoepelman RJ, Spijkerman R, et al. Persistent inflammation, immunosuppression and catabolism syndrome (PICS) after polytrauma: A rare syndrome with major consequences. J Clin Med Res. 2020;9(1):191.</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Ingraham</surname><given-names>NE</given-names></name><name><surname>Tignanelli</surname><given-names>CJ</given-names></name><name><surname>Menk</surname><given-names>J</given-names></name><name><surname>Chipman</surname><given-names>JG</given-names></name></person-group><article-title>Pre- and peri-operative factors associated with chronic critical illness in liver transplant recipients</article-title><source>Surg Infect</source><year>2020</year><volume>21</volume><issue>3</issue><fpage>246</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1089/sur.2019.192</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Ingraham NE, Tignanelli CJ, Menk J, Chipman JG. Pre- and peri-operative factors associated with chronic critical illness in liver transplant recipients. Surg Infect. 2020;21(3):246&#x02013;54.</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Mankowski</surname><given-names>RT</given-names></name><name><surname>Anton</surname><given-names>SD</given-names></name><name><surname>Ghita</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Older sepsis survivors suffer persistent disability burden and poor long-term survival</article-title><source>J Am Geriatr Soc</source><year>2020</year><volume>68</volume><issue>9</issue><fpage>1962</fpage><lpage>1969</lpage><pub-id pub-id-type="doi">10.1111/jgs.16435</pub-id><pub-id pub-id-type="pmid">32294254</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Mankowski RT, Anton SD, Ghita GL, et al. Older sepsis survivors suffer persistent disability burden and poor long-term survival. J Am Geriatr Soc. 2020;68(9):1962&#x02013;9.<pub-id pub-id-type="pmid">32294254</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>MD</given-names></name><name><surname>Bala</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Loftus</surname><given-names>T</given-names></name><name><surname>Moore</surname><given-names>F</given-names></name></person-group><article-title>Chronic critical illness patients fail to respond to current evidence-based intensive care nutrition secondarily to persistent inflammation, immunosuppression, and catabolic syndrome</article-title><source>JPEN J Parenter Enteral Nutr</source><year>2020</year><volume>44</volume><issue>7</issue><fpage>1237</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1002/jpen.1794</pub-id><pub-id pub-id-type="pmid">32026502</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Rosenthal MD, Bala T, Wang Z, Loftus T, Moore F. Chronic critical illness patients fail to respond to current evidence-based intensive care nutrition secondarily to persistent inflammation, immunosuppression, and catabolic syndrome. JPEN J Parenter Enteral Nutr. 2020;44(7):1237&#x02013;49.<pub-id pub-id-type="pmid">32026502</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Stortz</surname><given-names>JA</given-names></name><name><surname>Cox</surname><given-names>MC</given-names></name><name><surname>Hawkins</surname><given-names>RB</given-names></name><etal/></person-group><article-title>Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study</article-title><source>Crit Care</source><year>2020</year><volume>24</volume><issue>1</issue><fpage>203</fpage><pub-id pub-id-type="doi">10.1186/s13054-020-02917-3</pub-id><pub-id pub-id-type="pmid">32381107</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Stortz JA, Cox MC, Hawkins RB, et al. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study. Crit Care. 2020;24(1):203.<pub-id pub-id-type="pmid">32381107</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Wintermann</surname><given-names>GB</given-names></name><name><surname>Weidner</surname><given-names>K</given-names></name><name><surname>Strauss</surname><given-names>B</given-names></name><name><surname>Rosendahl</surname><given-names>J</given-names></name></person-group><article-title>Single assessment of delirium severity during postacute intensive care of chronically critically ill patients and its associated factors: post hoc analysis of a prospective cohort study in Germany</article-title><source>BMJ Open</source><year>2020</year><volume>10</volume><issue>10</issue><fpage>e035733</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2019-035733</pub-id><pub-id pub-id-type="pmid">33033083</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Wintermann GB, Weidner K, Strauss B, Rosendahl J. Single assessment of delirium severity during postacute intensive care of chronically critically ill patients and its associated factors: post hoc analysis of a prospective cohort study in Germany. BMJ Open. 2020;10(10):e035733.<pub-id pub-id-type="pmid">33033083</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Cox</surname><given-names>M</given-names></name><etal/></person-group><article-title>Distinct immunologic endotypes are associated with clinical trajectory after severe blunt trauma and hemorrhagic shock</article-title><source>J Trauma Acute Care Surg</source><year>2021</year><volume>90</volume><issue>2</issue><fpage>257</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1097/TA.0000000000003029</pub-id><pub-id pub-id-type="pmid">33214489</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Brakenridge SC, Wang Z, Cox M, et al. Distinct immunologic endotypes are associated with clinical trajectory after severe blunt trauma and hemorrhagic shock. J Trauma Acute Care Surg. 2021;90(2):257&#x02013;67.<pub-id pub-id-type="pmid">33214489</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>MC</given-names></name><name><surname>Booth</surname><given-names>M</given-names></name><name><surname>Ghita</surname><given-names>G</given-names></name><etal/></person-group><article-title>The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsis</article-title><source>J Cachexia Sarcopenia Muscle</source><year>2021</year><volume>12</volume><issue>5</issue><fpage>1203</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1002/jcsm.12752</pub-id><pub-id pub-id-type="pmid">34196134</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Cox MC, Booth M, Ghita G, et al. The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsis. J Cachexia Sarcopenia Muscle. 2021;12(5):1203&#x02013;13.<pub-id pub-id-type="pmid">34196134</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname><given-names>DB</given-names></name><name><surname>Ghita</surname><given-names>GL</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Chronic critical illness elicits a unique circulating leukocyte transcriptome in sepsis survivors</article-title><source>J Clin Med Res</source><year>2021</year><volume>10</volume><issue>15</issue><fpage>3211</fpage></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Darden DB, Ghita GL, Wang Z, et al. Chronic critical illness elicits a unique circulating leukocyte transcriptome in sepsis survivors. J Clin Med Res. 2021;10(15):3211.</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname><given-names>DB</given-names></name><name><surname>Brakenridge</surname><given-names>SC</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) in chronic critical illness (CCI) after surgical sepsis</article-title><source>Ann Surg</source><year>2021</year><volume>274</volume><issue>4</issue><fpage>664</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000005067</pub-id><pub-id pub-id-type="pmid">34506322</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Darden DB, Brakenridge SC, Efron PA, et al. Biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) in chronic critical illness (CCI) after surgical sepsis. Ann Surg. 2021;274(4):664&#x02013;73.<pub-id pub-id-type="pmid">34506322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Dubin</surname><given-names>R</given-names></name><name><surname>Veith</surname><given-names>JM</given-names></name><name><surname>Grippi</surname><given-names>MA</given-names></name><name><surname>McPeake</surname><given-names>J</given-names></name><name><surname>Harhay</surname><given-names>MO</given-names></name><name><surname>Mikkelsen</surname><given-names>ME</given-names></name></person-group><article-title>Functional outcomes, goals, and goal attainment among chronically critically ill long-term acute care hospital patients</article-title><source>Ann Am Thorac Soc</source><year>2021</year><volume>18</volume><issue>12</issue><fpage>2041</fpage><lpage>2048</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.202011-1412OC</pub-id><pub-id pub-id-type="pmid">33984248</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Dubin R, Veith JM, Grippi MA, McPeake J, Harhay MO, Mikkelsen ME. Functional outcomes, goals, and goal attainment among chronically critically ill long-term acute care hospital patients. Ann Am Thorac Soc. 2021;18(12):2041&#x02013;8.<pub-id pub-id-type="pmid">33984248</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Guirgis</surname><given-names>FW</given-names></name><name><surname>Black</surname><given-names>LP</given-names></name><name><surname>Henson</surname><given-names>M</given-names></name><etal/></person-group><article-title>A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes</article-title><source>Crit Care</source><year>2021</year><volume>25</volume><issue>1</issue><fpage>341</fpage><pub-id pub-id-type="doi">10.1186/s13054-021-03757-5</pub-id><pub-id pub-id-type="pmid">34535154</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Guirgis FW, Black LP, Henson M, et al. A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes. Crit Care. 2021;25(1):341.<pub-id pub-id-type="pmid">34535154</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>DL</given-names></name><name><surname>Bettcher</surname><given-names>LF</given-names></name><name><surname>Navarro</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Persistent metabolomic alterations characterize chronic critical illness after severe trauma</article-title><source>J Trauma Acute Care Surg</source><year>2021</year><volume>90</volume><issue>1</issue><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1097/TA.0000000000002952</pub-id><pub-id pub-id-type="pmid">33017357</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Horn DL, Bettcher LF, Navarro SL, et al. Persistent metabolomic alterations characterize chronic critical illness after severe trauma. J Trauma Acute Care Surg. 2021;90(1):35&#x02013;45.<pub-id pub-id-type="pmid">33017357</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>D</given-names></name><name><surname>Maine</surname><given-names>R</given-names></name><name><surname>Cook</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chronic critical illness after hypothermia in trauma patients</article-title><source>Trauma Surg Acute Care Open</source><year>2021</year><volume>6</volume><issue>1</issue><fpage>e000747</fpage><pub-id pub-id-type="doi">10.1136/tsaco-2021-000747</pub-id><pub-id pub-id-type="pmid">34423134</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Miranda D, Maine R, Cook M, et al. Chronic critical illness after hypothermia in trauma patients. Trauma Surg Acute Care Open. 2021;6(1):e000747.<pub-id pub-id-type="pmid">34423134</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Ohbe</surname><given-names>H</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Fushimi</surname><given-names>K</given-names></name><name><surname>Yasunaga</surname><given-names>H</given-names></name></person-group><article-title>Epidemiology of chronic critical illness in Japan: a nationwide inpatient database study</article-title><source>Crit Care Med</source><year>2021</year><volume>49</volume><issue>1</issue><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000004723</pub-id><pub-id pub-id-type="pmid">33177360</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Ohbe H, Matsui H, Fushimi K, Yasunaga H. Epidemiology of chronic critical illness in Japan: a nationwide inpatient database study. Crit Care Med. 2021;49(1):70&#x02013;8.<pub-id pub-id-type="pmid">33177360</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Wendlandt</surname><given-names>B</given-names></name><name><surname>Ceppe</surname><given-names>A</given-names></name><name><surname>Cox</surname><given-names>CE</given-names></name><name><surname>Hanson</surname><given-names>LC</given-names></name><name><surname>Nelson</surname><given-names>JE</given-names></name><name><surname>Carson</surname><given-names>SS</given-names></name></person-group><article-title>The association between patient health status and surrogate decision maker post-traumatic stress disorder symptoms in chronic critical illness</article-title><source>Ann Am Thorac Soc</source><year>2021</year><volume>18</volume><issue>11</issue><fpage>1868</fpage><lpage>1875</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.202010-1300OC</pub-id><pub-id pub-id-type="pmid">33794122</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Wendlandt B, Ceppe A, Cox CE, Hanson LC, Nelson JE, Carson SS. The association between patient health status and surrogate decision maker post-traumatic stress disorder symptoms in chronic critical illness. Ann Am Thorac Soc. 2021;18(11):1868&#x02013;75.<pub-id pub-id-type="pmid">33794122</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Sirtuin 2 expression levels may predict the progression of sepsis survivors to chronic critical illness</article-title><source>Ann Transl Med</source><year>2021</year><volume>9</volume><issue>2</issue><fpage>150</fpage><pub-id pub-id-type="doi">10.21037/atm-20-7975</pub-id><pub-id pub-id-type="pmid">33569452</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Xu H, Li J, Yu X, et al. Sirtuin 2 expression levels may predict the progression of sepsis survivors to chronic critical illness. Ann Transl Med. 2021;9(2):150.<pub-id pub-id-type="pmid">33569452</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Yildirim</surname><given-names>S</given-names></name><name><surname>Durmaz</surname><given-names>Y</given-names></name><name><surname>&#x0015e;an</surname><given-names>Y</given-names></name><name><surname>Ta&#x0015f;k&#x00131;ran</surname><given-names>&#x00130;</given-names></name><name><surname>Cinleti</surname><given-names>BA</given-names></name><name><surname>Kirakli</surname><given-names>C</given-names></name></person-group><article-title>Cost of chronic critically ill patients to the healthcare system: a single-center experience from a developing country</article-title><source>Indian J Crit Care Med</source><year>2021</year><volume>25</volume><issue>5</issue><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.5005/jp-journals-10071-23804</pub-id><pub-id pub-id-type="pmid">34177170</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Yildirim S, Durmaz Y, &#x0015e;an Y, Ta&#x0015f;k&#x00131;ran &#x00130;, Cinleti BA, Kirakli C. Cost of chronic critically ill patients to the healthcare system: a single-center experience from a developing country. Indian J Crit Care Med. 2021;25(5):519&#x02013;23.<pub-id pub-id-type="pmid">34177170</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Ballesteros</surname><given-names>M&#x000c1;</given-names></name><name><surname>S&#x000e1;nchez-Arguiano</surname><given-names>MJ</given-names></name><name><surname>Chico-Fern&#x000e1;ndez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chronic critical illness in polytrauma. Results of the Spanish trauma in ICU registry</article-title><source>Acta Anaesthesiol Scand</source><year>2022</year><volume>66</volume><issue>6</issue><fpage>722</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1111/aas.14065</pub-id><pub-id pub-id-type="pmid">35332519</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Ballesteros M&#x000c1;, S&#x000e1;nchez-Arguiano MJ, Chico-Fern&#x000e1;ndez M, et al. Chronic critical illness in polytrauma. Results of the Spanish trauma in ICU registry. Acta Anaesthesiol Scand. 2022;66(6):722&#x02013;30.<pub-id pub-id-type="pmid">35332519</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Madushani</surname><given-names>RWMA</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Loftus</surname><given-names>T</given-names></name><etal/></person-group><article-title>Early biomarker signatures in surgical sepsis</article-title><source>J Surg Res</source><year>2022</year><volume>277</volume><fpage>372</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2022.04.052</pub-id><pub-id pub-id-type="pmid">35569215</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Madushani RWMA, Patel V, Loftus T, et al. Early biomarker signatures in surgical sepsis. J Surg Res. 2022;277:372&#x02013;83.<pub-id pub-id-type="pmid">35569215</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Mankowski</surname><given-names>RT</given-names></name><name><surname>Anton</surname><given-names>SD</given-names></name><name><surname>Ghita</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression, and catabolism syndrome (PICS) after sepsis</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2022</year><volume>77</volume><issue>1</issue><fpage>188</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1093/gerona/glab080</pub-id><pub-id pub-id-type="pmid">33721883</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Mankowski RT, Anton SD, Ghita GL, et al. Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression, and catabolism syndrome (PICS) after sepsis. J Gerontol A Biol Sci Med Sci. 2022;77(1):188&#x02013;96.<pub-id pub-id-type="pmid">33721883</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Roedl</surname><given-names>K</given-names></name><name><surname>Jarczak</surname><given-names>D</given-names></name><name><surname>Boenisch</surname><given-names>O</given-names></name><etal/></person-group><article-title>Chronic critical illness in patients with COVID-19: characteristics and outcome of prolonged intensive care therapy</article-title><source>J Clin Med Res</source><year>2022</year><volume>11</volume><issue>4</issue><fpage>1049</fpage></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Roedl K, Jarczak D, Boenisch O, et al. Chronic critical illness in patients with COVID-19: characteristics and outcome of prolonged intensive care therapy. J Clin Med Res. 2022;11(4):1049.</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Wendlandt</surname><given-names>B</given-names></name><name><surname>Ceppe</surname><given-names>A</given-names></name><name><surname>Gaynes</surname><given-names>BN</given-names></name><etal/></person-group><article-title>Posttraumatic stress disorder symptom clusters in surrogate decision makers of patients experiencing chronic critical illness</article-title><source>Crit Care Explor</source><year>2022</year><volume>4</volume><issue>3</issue><fpage>e0647</fpage><pub-id pub-id-type="doi">10.1097/CCE.0000000000000647</pub-id><pub-id pub-id-type="pmid">35261980</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Wendlandt B, Ceppe A, Gaynes BN, et al. Posttraumatic stress disorder symptom clusters in surrogate decision makers of patients experiencing chronic critical illness. Crit Care Explor. 2022;4(3):e0647.<pub-id pub-id-type="pmid">35261980</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Balch</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>UI</given-names></name><name><surname>Liesenfeld</surname><given-names>O</given-names></name><etal/></person-group><article-title>Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study</article-title><source>Crit Care</source><year>2023</year><volume>27</volume><issue>1</issue><fpage>292</fpage><pub-id pub-id-type="doi">10.1186/s13054-023-04571-x</pub-id><pub-id pub-id-type="pmid">37474944</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Balch JA, Chen UI, Liesenfeld O, et al. Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study. Crit Care. 2023;27(1):292.<pub-id pub-id-type="pmid">37474944</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>SR</given-names></name><name><surname>Sacha</surname><given-names>GL</given-names></name><name><surname>Siuba</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Vasopressin response and clinical trajectory in septic shock patients</article-title><source>J Intensive Care Med</source><year>2023</year><volume>38</volume><issue>3</issue><fpage>273</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1177/08850666221118282</pub-id><pub-id pub-id-type="pmid">36062611</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Bauer SR, Sacha GL, Siuba MT, et al. Vasopressin response and clinical trajectory in septic shock patients. J Intensive Care Med. 2023;38(3):273&#x02013;9.<pub-id pub-id-type="pmid">36062611</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Carmichael</surname><given-names>ED</given-names></name><name><surname>Apple</surname><given-names>CG</given-names></name><name><surname>Kannan</surname><given-names>KB</given-names></name><etal/></person-group><article-title>Chronic critical illness in patients with sepsis is associated with persistent anemia, inflammation, and impaired functional outcomes</article-title><source>Am Surg</source><year>2023</year><volume>89</volume><issue>6</issue><fpage>2563</fpage><lpage>2571</lpage><pub-id pub-id-type="doi">10.1177/00031348221104252</pub-id><pub-id pub-id-type="pmid">35593749</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Carmichael ED, Apple CG, Kannan KB, et al. Chronic critical illness in patients with sepsis is associated with persistent anemia, inflammation, and impaired functional outcomes. Am Surg. 2023;89(6):2563&#x02013;71.<pub-id pub-id-type="pmid">35593749</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><etal/></person-group><article-title>Subphenotyping heterogeneous patients with chronic critical illness to guide individualised fluid balance treatment using machine learning: a retrospective cohort study</article-title><source>EClinicalMedicine</source><year>2023</year><volume>59</volume><issue>101970</issue><fpage>101970</fpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2023.101970</pub-id><pub-id pub-id-type="pmid">37131542</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Liu P, Li S, Zheng T, et al. Subphenotyping heterogeneous patients with chronic critical illness to guide individualised fluid balance treatment using machine learning: a retrospective cohort study. EClinicalMedicine. 2023;59(101970):101970.<pub-id pub-id-type="pmid">37131542</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Madahar</surname><given-names>P</given-names></name><name><surname>Capaccione</surname><given-names>KM</given-names></name><name><surname>Salvatore</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Fibrotic-like pulmonary radiographic patterns are not associated with adverse outcomes in COVID-19 chronic critical illness</article-title><source>Crit Care Med</source><year>2023</year><volume>51</volume><issue>11</issue><fpage>e209</fpage><lpage>e220</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000005954</pub-id><pub-id pub-id-type="pmid">37294143</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Madahar P, Capaccione KM, Salvatore MM, et al. Fibrotic-like pulmonary radiographic patterns are not associated with adverse outcomes in COVID-19 chronic critical illness. Crit Care Med. 2023;51(11):e209&#x02013;20.<pub-id pub-id-type="pmid">37294143</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Roccasecca Sampaio Gaia</surname><given-names>V</given-names></name><name><surname>Costa</surname><given-names>ELV</given-names></name><name><surname>Yamaguti</surname><given-names>WP</given-names></name><name><surname>de Francisco</surname><given-names>DS</given-names></name><name><surname>Fumis</surname><given-names>RRL</given-names></name></person-group><article-title>Functional recovery of chronically critically ill patients in the first days after discharge from the intensive care unit: Feasibility of the 6-minute step test</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><issue>11</issue><fpage>e0293747</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0293747</pub-id><pub-id pub-id-type="pmid">37917777</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Roccasecca Sampaio Gaia V, Costa ELV, Yamaguti WP, de Francisco DS, Fumis RRL. Functional recovery of chronically critically ill patients in the first days after discharge from the intensive care unit: Feasibility of the 6-minute step test. PLoS ONE. 2023;18(11):e0293747.<pub-id pub-id-type="pmid">37917777</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Arguiano</surname><given-names>MJ</given-names></name><name><surname>Mi&#x000f1;ambres</surname><given-names>E</given-names></name><name><surname>Cuenca-Fito</surname><given-names>E</given-names></name><name><surname>Suberviola</surname><given-names>B</given-names></name><name><surname>Bur&#x000f3;n-Mediavilla</surname><given-names>FJ</given-names></name><name><surname>Ballesteros</surname><given-names>MA</given-names></name></person-group><article-title>Chronic critical illness after trauma injury: outcomes and experience in a trauma center</article-title><source>Acta Chir Belg</source><year>2023</year><volume>123</volume><issue>6</issue><fpage>618</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1080/00015458.2022.2106626</pub-id><pub-id pub-id-type="pmid">35881765</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">S&#x000e1;nchez-Arguiano MJ, Mi&#x000f1;ambres E, Cuenca-Fito E, Suberviola B, Bur&#x000f3;n-Mediavilla FJ, Ballesteros MA. Chronic critical illness after trauma injury: outcomes and experience in a trauma center. Acta Chir Belg. 2023;123(6):618&#x02013;24.<pub-id pub-id-type="pmid">35881765</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>K</given-names></name><name><surname>Qiu</surname><given-names>Q</given-names></name><name><surname>Weykamp</surname><given-names>M</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>G</given-names></name><name><surname>Brakenridge</surname><given-names>SC</given-names></name></person-group><article-title>Defining posttraumatic sepsis for population-level research</article-title><source>JAMA Netw Open</source><year>2023</year><volume>6</volume><issue>1</issue><fpage>e2251445</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.51445</pub-id><pub-id pub-id-type="pmid">36652245</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Stern K, Qiu Q, Weykamp M, O&#x02019;Keefe G, Brakenridge SC. Defining posttraumatic sepsis for population-level research. JAMA Netw Open. 2023;6(1):e2251445.<pub-id pub-id-type="pmid">36652245</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Mu</surname><given-names>G</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name></person-group><article-title>Predictive value of soluble programmed cell death ligand-1 in the progression of septic patients to chronic critical illness in the intensive care unit: a prospective observational clinical study</article-title><source>Shock</source><year>2023</year><volume>60</volume><issue>2</issue><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1097/SHK.0000000000002156</pub-id><pub-id pub-id-type="pmid">37267247</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Zeng C, Li X, Lu Z, Mu G, Deng Y. Predictive value of soluble programmed cell death ligand-1 in the progression of septic patients to chronic critical illness in the intensive care unit: a prospective observational clinical study. Shock. 2023;60(2):163&#x02013;71.<pub-id pub-id-type="pmid">37267247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Clinical and prognostic features of chronic critical illness/persistent inflammation immunosuppression and catabolism patients: a prospective observational clinical study</article-title><source>Shock</source><year>2023</year><volume>59</volume><issue>1</issue><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">36383370</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Zhou Q, Qian H, Yang A, Lu J, Liu J. Clinical and prognostic features of chronic critical illness/persistent inflammation immunosuppression and catabolism patients: a prospective observational clinical study. Shock. 2023;59(1):5&#x02013;11.<pub-id pub-id-type="pmid">36383370</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>KP</given-names></name><name><surname>Su</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><etal/></person-group><article-title>Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness</article-title><source>Front Immunol</source><year>2024</year><volume>15</volume><fpage>1334882</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2024.1334882</pub-id><pub-id pub-id-type="pmid">38426112</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Chung KP, Su JY, Wang YF, et al. Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness. Front Immunol. 2024;15:1334882.<pub-id pub-id-type="pmid">38426112</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Cuschieri</surname><given-names>J</given-names></name><name><surname>Kornblith</surname><given-names>L</given-names></name><name><surname>Pati</surname><given-names>S</given-names></name><name><surname>Piliponsky</surname><given-names>A</given-names></name></person-group><article-title>The injured monocyte: the link to chronic critical illness and mortality following injury</article-title><source>J Trauma Acute Care Surg</source><year>2024</year><volume>96</volume><issue>2</issue><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">37880827</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Cuschieri J, Kornblith L, Pati S, Piliponsky A. The injured monocyte: the link to chronic critical illness and mortality following injury. J Trauma Acute Care Surg. 2024;96(2):195&#x02013;202.<pub-id pub-id-type="pmid">37880827</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Wimmer</surname><given-names>C</given-names></name><name><surname>Stummer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reduced health-related quality of life, fatigue, anxiety and depression affect COVID-19 patients in the long-term after chronic critical illness</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>3016</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-52908-5</pub-id><pub-id pub-id-type="pmid">38321074</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Egger M, Wimmer C, Stummer S, et al. Reduced health-related quality of life, fatigue, anxiety and depression affect COVID-19 patients in the long-term after chronic critical illness. Sci Rep. 2024;14(1):3016.<pub-id pub-id-type="pmid">38321074</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Halacli</surname><given-names>B</given-names></name><name><surname>Yildirim</surname><given-names>M</given-names></name><name><surname>Kaya</surname><given-names>EK</given-names></name><name><surname>Ulusoydan</surname><given-names>E</given-names></name><name><surname>Ersoy</surname><given-names>EO</given-names></name><name><surname>Topeli</surname><given-names>A</given-names></name></person-group><article-title>Chronic critical illness in critically ill COVID-19 patients</article-title><source>Chronic Illn</source><year>2024</year><volume>20</volume><issue>1</issue><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1177/17423953231161333</pub-id><pub-id pub-id-type="pmid">36883242</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Halacli B, Yildirim M, Kaya EK, Ulusoydan E, Ersoy EO, Topeli A. Chronic critical illness in critically ill COVID-19 patients. Chronic Illn. 2024;20(1):86&#x02013;95.<pub-id pub-id-type="pmid">36883242</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Maurer</surname><given-names>C</given-names></name><name><surname>Exl</surname><given-names>MT</given-names></name><name><surname>Gander</surname><given-names>HP</given-names></name><etal/></person-group><article-title>Consequences of a stay in the intensive care unit and outpatient follow-up care for chronic critically ill patients: a retrospective data analysis</article-title><source>Aust Crit Care</source><year>2024</year><volume>37</volume><issue>6</issue><fpage>931</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.aucc.2024.05.011</pub-id><pub-id pub-id-type="pmid">38971649</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Maurer C, Exl MT, Gander HP, et al. Consequences of a stay in the intensive care unit and outpatient follow-up care for chronic critically ill patients: a retrospective data analysis. Aust Crit Care. 2024;37(6):931&#x02013;9.<pub-id pub-id-type="pmid">38971649</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Black</surname><given-names>LP</given-names></name><etal/></person-group><article-title>Lipidomic changes in a novel sepsis outcome-based analysis reveals potent pro-inflammatory and pro-resolving signaling lipids</article-title><source>Clin Transl Sci</source><year>2024</year><volume>17</volume><issue>3</issue><fpage>e13745</fpage><pub-id pub-id-type="doi">10.1111/cts.13745</pub-id><pub-id pub-id-type="pmid">38488489</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Sulaiman D, Wu D, Black LP, et al. Lipidomic changes in a novel sepsis outcome-based analysis reveals potent pro-inflammatory and pro-resolving signaling lipids. Clin Transl Sci. 2024;17(3):e13745.<pub-id pub-id-type="pmid">38488489</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>The obesity paradox and 90 day mortality in chronic critically ill patients: a cohort study using a large clinical database</article-title><source>Eur J Med Res</source><year>2024</year><volume>29</volume><issue>1</issue><fpage>392</fpage><pub-id pub-id-type="doi">10.1186/s40001-024-01962-w</pub-id><pub-id pub-id-type="pmid">39075583</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Xu D, Lu Y, Wang Y, Li F. The obesity paradox and 90 day mortality in chronic critically ill patients: a cohort study using a large clinical database. Eur J Med Res. 2024;29(1):392.<pub-id pub-id-type="pmid">39075583</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Iwashyna</surname><given-names>TJ</given-names></name><name><surname>Hodgson</surname><given-names>CL</given-names></name><name><surname>Pilcher</surname><given-names>D</given-names></name><etal/></person-group><article-title>Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study</article-title><source>Lancet Respir Med</source><year>2016</year><volume>4</volume><issue>7</issue><fpage>566</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(16)30098-4</pub-id><pub-id pub-id-type="pmid">27155770</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Iwashyna TJ, Hodgson CL, Pilcher D, et al. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. Lancet Respir Med. 2016;4(7):566&#x02013;73.<pub-id pub-id-type="pmid">27155770</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Darvall</surname><given-names>JN</given-names></name><name><surname>Boonstra</surname><given-names>T</given-names></name><name><surname>Norman</surname><given-names>J</given-names></name><etal/></person-group><article-title>Persistent critical illness: baseline characteristics, intensive care course, and cause of death</article-title><source>Crit Care Resusc</source><year>2019</year><volume>21</volume><issue>2</issue><fpage>110</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">31142241</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Darvall JN, Boonstra T, Norman J, et al. Persistent critical illness: baseline characteristics, intensive care course, and cause of death. Crit Care Resusc. 2019;21(2):110&#x02013;8.<pub-id pub-id-type="pmid">31142241</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>RW</given-names></name><name><surname>Zolfaghari</surname><given-names>P</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Pearse</surname><given-names>RM</given-names></name><name><surname>Puthucheary</surname><given-names>Z</given-names></name><name><surname>Prowle</surname><given-names>JR</given-names></name></person-group><article-title>Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma</article-title><source>Intensive Care Med</source><year>2019</year><volume>45</volume><issue>12</issue><fpage>1718</fpage><lpage>1731</lpage><pub-id pub-id-type="doi">10.1007/s00134-019-05760-5</pub-id><pub-id pub-id-type="pmid">31531715</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Haines RW, Zolfaghari P, Wan Y, Pearse RM, Puthucheary Z, Prowle JR. Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma. Intensive Care Med. 2019;45(12):1718&#x02013;31.<pub-id pub-id-type="pmid">31531715</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffcote</surname><given-names>T</given-names></name><name><surname>Foong</surname><given-names>M</given-names></name><name><surname>Gold</surname><given-names>G</given-names></name><etal/></person-group><article-title>Patient characteristics, ICU-specific supports, complications, and outcomes of persistent critical illness</article-title><source>J Crit Care</source><year>2019</year><volume>54</volume><fpage>250</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.jcrc.2019.08.023</pub-id><pub-id pub-id-type="pmid">31630075</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Jeffcote T, Foong M, Gold G, et al. Patient characteristics, ICU-specific supports, complications, and outcomes of persistent critical illness. J Crit Care. 2019;54:250&#x02013;5.<pub-id pub-id-type="pmid">31630075</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Viglianti</surname><given-names>EM</given-names></name><name><surname>Zajic</surname><given-names>P</given-names></name><name><surname>Iwashyna</surname><given-names>TJ</given-names></name><name><surname>Amrein</surname><given-names>K</given-names></name></person-group><article-title>Neither vitamin D levels nor supplementation are associated with the development of persistent critical illness: a retrospective cohort analysis</article-title><source>Crit Care Resusc</source><year>2019</year><volume>21</volume><issue>1</issue><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">30857511</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Viglianti EM, Zajic P, Iwashyna TJ, Amrein K. Neither vitamin D levels nor supplementation are associated with the development of persistent critical illness: a retrospective cohort analysis. Crit Care Resusc. 2019;21(1):39&#x02013;44.<pub-id pub-id-type="pmid">30857511</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Viglianti</surname><given-names>EM</given-names></name><name><surname>McPeake</surname><given-names>J</given-names></name><etal/></person-group><article-title>Timing of onset, burden, and postdischarge mortality of persistent critical illness in Scotland, 2005&#x02013;2014: a retrospective, population-based, observational study</article-title><source>Crit Care Explor</source><year>2020</year><volume>2</volume><issue>4</issue><fpage>e0102</fpage><pub-id pub-id-type="doi">10.1097/CCE.0000000000000102</pub-id><pub-id pub-id-type="pmid">32426744</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Shaw M, Viglianti EM, McPeake J, et al. Timing of onset, burden, and postdischarge mortality of persistent critical illness in Scotland, 2005&#x02013;2014: a retrospective, population-based, observational study. Crit Care Explor. 2020;2(4):e0102.<pub-id pub-id-type="pmid">32426744</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Tseitkin</surname><given-names>B</given-names></name><name><surname>M&#x000e5;rtensson</surname><given-names>J</given-names></name><name><surname>Eastwood</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Nature and impact of in-hospital complications associated with persistent critical illness</article-title><source>Crit Care Resusc</source><year>2020</year><volume>22</volume><issue>4</issue><fpage>378</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">38046870</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Tseitkin B, M&#x000e5;rtensson J, Eastwood GM, et al. Nature and impact of in-hospital complications associated with persistent critical illness. Crit Care Resusc. 2020;22(4):378&#x02013;87.<pub-id pub-id-type="pmid">38046870</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Viglianti</surname><given-names>EM</given-names></name><name><surname>Bagshaw</surname><given-names>SM</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><etal/></person-group><article-title>Hospital-level variation in the development of persistent critical illness</article-title><source>Intensive Care Med</source><year>2020</year><volume>46</volume><issue>8</issue><fpage>1567</fpage><lpage>1575</lpage><pub-id pub-id-type="doi">10.1007/s00134-020-06129-9</pub-id><pub-id pub-id-type="pmid">32500182</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Viglianti EM, Bagshaw SM, Bellomo R, et al. Hospital-level variation in the development of persistent critical illness. Intensive Care Med. 2020;46(8):1567&#x02013;75.<pub-id pub-id-type="pmid">32500182</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>MV</given-names></name><name><surname>Pantet</surname><given-names>O</given-names></name><name><surname>Charri&#x000e8;re</surname><given-names>M</given-names></name><etal/></person-group><article-title>Improving nutritional therapy of persistent critically ill patients by organisational measures: a before and after study</article-title><source>Clin Nutr ESPEN</source><year>2021</year><volume>46</volume><fpage>459</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/j.clnesp.2021.09.009</pub-id><pub-id pub-id-type="pmid">34857234</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Viana MV, Pantet O, Charri&#x000e8;re M, et al. Improving nutritional therapy of persistent critically ill patients by organisational measures: a before and after study. Clin Nutr ESPEN. 2021;46:459&#x02013;65.<pub-id pub-id-type="pmid">34857234</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Blayney</surname><given-names>MC</given-names></name><name><surname>Stewart</surname><given-names>NI</given-names></name><name><surname>Kaye</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Prevalence, characteristics, and longer-term outcomes of patients with persistent critical illness attributable to COVID-19 in Scotland: a national cohort study</article-title><source>Br J Anaesth</source><year>2022</year><volume>128</volume><issue>6</issue><fpage>980</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2022.03.017</pub-id><pub-id pub-id-type="pmid">35465954</pub-id>
</element-citation><mixed-citation id="mc-CR93" publication-type="journal">Blayney MC, Stewart NI, Kaye CT, et al. Prevalence, characteristics, and longer-term outcomes of patients with persistent critical illness attributable to COVID-19 in Scotland: a national cohort study. Br J Anaesth. 2022;128(6):980&#x02013;9.<pub-id pub-id-type="pmid">35465954</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Darvall</surname><given-names>JN</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Bailey</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>PJ</given-names></name><name><surname>Rockwood</surname><given-names>K</given-names></name><name><surname>Pilcher</surname><given-names>D</given-names></name></person-group><article-title>Impact of frailty on persistent critical illness: a population-based cohort study</article-title><source>Intensive Care Med</source><year>2022</year><volume>48</volume><issue>3</issue><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1007/s00134-022-06617-0</pub-id><pub-id pub-id-type="pmid">35119497</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Darvall JN, Bellomo R, Bailey M, Young PJ, Rockwood K, Pilcher D. Impact of frailty on persistent critical illness: a population-based cohort study. Intensive Care Med. 2022;48(3):343&#x02013;51.<pub-id pub-id-type="pmid">35119497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>RW</given-names></name><name><surname>Fowler</surname><given-names>AJ</given-names></name><name><surname>Wan</surname><given-names>YI</given-names></name><etal/></person-group><article-title>Catabolism in critical illness: a reanalysis of the REducing Deaths due to OXidative Stress (REDOXS) trial</article-title><source>Crit Care Med</source><year>2022</year><volume>50</volume><issue>7</issue><fpage>1072</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000005499</pub-id><pub-id pub-id-type="pmid">35220340</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Haines RW, Fowler AJ, Wan YI, et al. Catabolism in critical illness: a reanalysis of the REducing Deaths due to OXidative Stress (REDOXS) trial. Crit Care Med. 2022;50(7):1072&#x02013;82.<pub-id pub-id-type="pmid">35220340</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Biological signatures and prediction of an immunosuppressive status-persistent critical illness-among orthopedic trauma patients using machine learning techniques</article-title><source>Front Immunol</source><year>2022</year><volume>13</volume><fpage>979877</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2022.979877</pub-id><pub-id pub-id-type="pmid">36325351</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Lei M, Han Z, Wang S, et al. Biological signatures and prediction of an immunosuppressive status-persistent critical illness-among orthopedic trauma patients using machine learning techniques. Front Immunol. 2022;13:979877.<pub-id pub-id-type="pmid">36325351</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>Viglianti</surname><given-names>EM</given-names></name><name><surname>Carlton</surname><given-names>EF</given-names></name><name><surname>McPeake</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>XQ</given-names></name><name><surname>Seelye</surname><given-names>S</given-names></name><name><surname>Iwashyna</surname><given-names>TJ</given-names></name></person-group><article-title>Acquisition of new medical devices among the persistently critically ill: a retrospective cohort study in the Veterans Affairs</article-title><source>Medicine</source><year>2022</year><volume>101</volume><issue>27</issue><fpage>e29821</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000029821</pub-id><pub-id pub-id-type="pmid">35801748</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">Viglianti EM, Carlton EF, McPeake J, Wang XQ, Seelye S, Iwashyna TJ. Acquisition of new medical devices among the persistently critically ill: a retrospective cohort study in the Veterans Affairs. Medicine. 2022;101(27):e29821.<pub-id pub-id-type="pmid">35801748</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Association of monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratios with persistent critical illness in patients with severe trauma</article-title><source>J Trauma Nurs</source><year>2022</year><volume>29</volume><issue>5</issue><fpage>240</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1097/JTN.0000000000000672</pub-id><pub-id pub-id-type="pmid">36095271</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Zhang B, Han Y, Chen X, et al. Association of monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratios with persistent critical illness in patients with severe trauma. J Trauma Nurs. 2022;29(5):240&#x02013;51.<pub-id pub-id-type="pmid">36095271</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DA</given-names></name><name><surname>Creagh-Brown</surname><given-names>BC</given-names></name><name><surname>Rowan</surname><given-names>KM</given-names></name></person-group><article-title>Timing and burden of persistent critical illnessin UK intensive care units: an observational cohort study</article-title><source>Pediatr Crit Care Med</source><year>2023</year><volume>24</volume><issue>2</issue><fpage>139</fpage><lpage>146</lpage></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Harrison DA, Creagh-Brown BC, Rowan KM. Timing and burden of persistent critical illnessin UK intensive care units: an observational cohort study. Pediatr Crit Care Med. 2023;24(2):139&#x02013;46.</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>RR</given-names></name><name><surname>Bonavia</surname><given-names>W</given-names></name><name><surname>Ponnapa Reddy</surname><given-names>M</given-names></name><name><surname>Pilcher</surname><given-names>D</given-names></name><name><surname>Subramaniam</surname><given-names>A</given-names></name></person-group><article-title>Persistent critical illness and long-term outcomes in patients with COVID-19: a multicenter retrospective cohort study</article-title><source>Crit Care Explor</source><year>2024</year><volume>6</volume><issue>3</issue><fpage>e1057</fpage><pub-id pub-id-type="doi">10.1097/CCE.0000000000001057</pub-id><pub-id pub-id-type="pmid">38425579</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Ling RR, Bonavia W, Ponnapa Reddy M, Pilcher D, Subramaniam A. Persistent critical illness and long-term outcomes in patients with COVID-19: a multicenter retrospective cohort study. Crit Care Explor. 2024;6(3):e1057.<pub-id pub-id-type="pmid">38425579</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Statlender</surname><given-names>L</given-names></name><name><surname>Shochat</surname><given-names>T</given-names></name><name><surname>Robinson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Urea to creatinine ratio as a predictor of persistent critical illness</article-title><source>J Crit Care</source><year>2024</year><volume>83</volume><fpage>154834</fpage><lpage>154834</lpage><pub-id pub-id-type="doi">10.1016/j.jcrc.2024.154834</pub-id><pub-id pub-id-type="pmid">38781812</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Statlender L, Shochat T, Robinson E, et al. Urea to creatinine ratio as a predictor of persistent critical illness. J Crit Care. 2024;83:154834&#x02013;154834.<pub-id pub-id-type="pmid">38781812</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Nierman</surname><given-names>DM</given-names></name><name><surname>Mechanick</surname><given-names>JI</given-names></name></person-group><article-title>Bone hyperresorption is prevalent in chronically critically ill patients</article-title><source>Chest</source><year>1998</year><volume>114</volume><issue>4</issue><fpage>1122</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1378/chest.114.4.1122</pub-id><pub-id pub-id-type="pmid">9792587</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest. 1998;114(4):1122&#x02013;8.<pub-id pub-id-type="pmid">9792587</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Nierman</surname><given-names>DM</given-names></name><name><surname>Mechanick</surname><given-names>JI</given-names></name></person-group><article-title>Hypotestosteronemia in chronically critically ill men</article-title><source>Crit Care Med</source><year>1999</year><volume>27</volume><issue>11</issue><fpage>2418</fpage><lpage>2421</lpage><pub-id pub-id-type="doi">10.1097/00003246-199911000-00016</pub-id><pub-id pub-id-type="pmid">10579258</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Nierman DM, Mechanick JI. Hypotestosteronemia in chronically critically ill men. Crit Care Med. 1999;27(11):2418&#x02013;21.<pub-id pub-id-type="pmid">10579258</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Nierman</surname><given-names>DM</given-names></name><name><surname>Mechanick</surname><given-names>JI</given-names></name></person-group><article-title>Biochemical response to treatment of bone hyperresorption in chronically critically ill patients</article-title><source>Chest</source><year>2000</year><volume>118</volume><issue>3</issue><fpage>761</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1378/chest.118.3.761</pub-id><pub-id pub-id-type="pmid">10988200</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Nierman DM, Mechanick JI. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest. 2000;118(3):761&#x02013;6.<pub-id pub-id-type="pmid">10988200</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Estenssoro</surname><given-names>E</given-names></name><name><surname>Reina</surname><given-names>R</given-names></name><name><surname>Canales</surname><given-names>HS</given-names></name><etal/></person-group><article-title>The distinct clinical profile of chronically critically ill patients: a cohort study</article-title><source>Crit Care</source><year>2006</year><volume>10</volume><issue>3</issue><fpage>R89</fpage><pub-id pub-id-type="doi">10.1186/cc4941</pub-id><pub-id pub-id-type="pmid">16784546</pub-id>
</element-citation><mixed-citation id="mc-CR105" publication-type="journal">Estenssoro E, Reina R, Canales HS, et al. The distinct clinical profile of chronically critically ill patients: a cohort study. Crit Care. 2006;10(3):R89.<pub-id pub-id-type="pmid">16784546</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Camhi</surname><given-names>SL</given-names></name><name><surname>Mercado</surname><given-names>AF</given-names></name><name><surname>Morrison</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Deciding in the dark: advance directives and continuation of treatment in chronic critical illness</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><issue>3</issue><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e31819613ce</pub-id><pub-id pub-id-type="pmid">19237897</pub-id>
</element-citation><mixed-citation id="mc-CR106" publication-type="journal">Camhi SL, Mercado AF, Morrison RS, et al. Deciding in the dark: advance directives and continuation of treatment in chronic critical illness. Crit Care Med. 2009;37(3):919&#x02013;25.<pub-id pub-id-type="pmid">19237897</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>BJ</given-names></name><name><surname>Douglas</surname><given-names>SL</given-names></name><name><surname>Gordon</surname><given-names>NH</given-names></name><etal/></person-group><article-title>Composite outcomes of chronically critically ill patients 4 months after hospital discharge</article-title><source>Am J Crit Care</source><year>2009</year><volume>18</volume><issue>5</issue><fpage>456</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.4037/ajcc2009580</pub-id><pub-id pub-id-type="pmid">19723866</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Daly BJ, Douglas SL, Gordon NH, et al. Composite outcomes of chronically critically ill patients 4 months after hospital discharge. Am J Crit Care. 2009;18(5):456&#x02013;64.<pub-id pub-id-type="pmid">19723866</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>Boniatti</surname><given-names>MM</given-names></name><name><surname>Giustina</surname><given-names>AD</given-names></name><name><surname>Marin</surname><given-names>LG</given-names></name><etal/></person-group><article-title>Mortality in chronically critically ill patients: expanding the use of the ProVent score</article-title><source>J Crit Care</source><year>2015</year><volume>30</volume><issue>5</issue><fpage>1039</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1016/j.jcrc.2015.06.022</pub-id><pub-id pub-id-type="pmid">26169543</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">Boniatti MM, Giustina AD, Marin LG, et al. Mortality in chronically critically ill patients: expanding the use of the ProVent score. J Crit Care. 2015;30(5):1039&#x02013;42.<pub-id pub-id-type="pmid">26169543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name><surname>Sancho</surname><given-names>J</given-names></name><name><surname>Servera</surname><given-names>E</given-names></name><name><surname>Jara-Palomares</surname><given-names>L</given-names></name><etal/></person-group><article-title>Noninvasive ventilation during the weaning process in chronically critically ill patients</article-title><source>ERJ Open Res</source><year>2016</year><volume>2</volume><issue>4</issue><fpage>00061</fpage><lpage>02016</lpage><pub-id pub-id-type="doi">10.1183/23120541.00061-2016</pub-id><pub-id pub-id-type="pmid">28053973</pub-id>
</element-citation><mixed-citation id="mc-CR109" publication-type="journal">Sancho J, Servera E, Jara-Palomares L, et al. Noninvasive ventilation during the weaning process in chronically critically ill patients. ERJ Open Res. 2016;2(4):00061&#x02013;2016.<pub-id pub-id-type="pmid">28053973</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Burridge</surname><given-names>JH</given-names></name><name><surname>Pohl</surname><given-names>M</given-names></name><name><surname>Oehmichen</surname><given-names>F</given-names></name><name><surname>Mehrholz</surname><given-names>J</given-names></name></person-group><article-title>Recovery of sit-to-stand function in patients with intensive-care-unit-acquired muscle weakness: results from the General Weakness Syndrome Therapy cohort study</article-title><source>J Rehabil Med</source><year>2016</year><volume>48</volume><issue>9</issue><fpage>793</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.2340/16501977-2135</pub-id><pub-id pub-id-type="pmid">27670853</pub-id>
</element-citation><mixed-citation id="mc-CR110" publication-type="journal">Thomas S, Burridge JH, Pohl M, Oehmichen F, Mehrholz J. Recovery of sit-to-stand function in patients with intensive-care-unit-acquired muscle weakness: results from the General Weakness Syndrome Therapy cohort study. J Rehabil Med. 2016;48(9):793&#x02013;8.<pub-id pub-id-type="pmid">27670853</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>MC</given-names></name><name><surname>Nicholson</surname><given-names>JP</given-names></name><name><surname>Park</surname><given-names>GR</given-names></name></person-group><article-title>Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness</article-title><source>Anaesthesia</source><year>1998</year><volume>53</volume><issue>8</issue><fpage>755</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2044.1998.00488.x</pub-id><pub-id pub-id-type="pmid">9797519</pub-id>
</element-citation><mixed-citation id="mc-CR111" publication-type="journal">Blunt MC, Nicholson JP, Park GR. Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness. Anaesthesia. 1998;53(8):755&#x02013;61.<pub-id pub-id-type="pmid">9797519</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berghe</surname><given-names>G</given-names></name><name><surname>Wouters</surname><given-names>P</given-names></name><name><surname>Carlsson</surname><given-names>L</given-names></name><name><surname>Baxter</surname><given-names>RC</given-names></name><name><surname>Bouillon</surname><given-names>R</given-names></name><name><surname>Bowers</surname><given-names>CY</given-names></name></person-group><article-title>Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone</article-title><source>J Clin Endocrinol Metab</source><year>1998</year><volume>83</volume><issue>9</issue><fpage>3062</fpage><lpage>3070</lpage><pub-id pub-id-type="pmid">9745404</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Van den Berghe G, Wouters P, Carlsson L, Baxter RC, Bouillon R, Bowers CY. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. J Clin Endocrinol Metab. 1998;83(9):3062&#x02013;70.<pub-id pub-id-type="pmid">9745404</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Nasraway</surname><given-names>SA</given-names></name><name><surname>Button</surname><given-names>GJ</given-names></name><name><surname>Rand</surname><given-names>WM</given-names></name><name><surname>Hudson-Jinks</surname><given-names>T</given-names></name><name><surname>Gustafson</surname><given-names>M</given-names></name></person-group><article-title>Survivors of catastrophic illness: outcome after direct transfer from intensive care to extended care facilities</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><issue>1</issue><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1097/00003246-200001000-00004</pub-id><pub-id pub-id-type="pmid">10667494</pub-id>
</element-citation><mixed-citation id="mc-CR113" publication-type="journal">Nasraway SA, Button GJ, Rand WM, Hudson-Jinks T, Gustafson M. Survivors of catastrophic illness: outcome after direct transfer from intensive care to extended care facilities. Crit Care Med. 2000;28(1):19&#x02013;25.<pub-id pub-id-type="pmid">10667494</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berghe</surname><given-names>G</given-names></name><name><surname>Baxter</surname><given-names>RC</given-names></name><name><surname>Weekers</surname><given-names>F</given-names></name><etal/></person-group><article-title>The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone</article-title><source>Clin Endocrinol</source><year>2002</year><volume>56</volume><issue>5</issue><fpage>655</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2265.2002.01255.x</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Van den Berghe G, Baxter RC, Weekers F, et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol. 2002;56(5):655&#x02013;69.</mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berghe</surname><given-names>G</given-names></name><name><surname>Van Roosbroeck</surname><given-names>D</given-names></name><name><surname>Vanhove</surname><given-names>P</given-names></name><name><surname>Wouters</surname><given-names>PJ</given-names></name><name><surname>De Pourcq</surname><given-names>L</given-names></name><name><surname>Bouillon</surname><given-names>R</given-names></name></person-group><article-title>Bone turnover in prolonged critical illness: effect of vitamin D</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><issue>10</issue><fpage>4623</fpage><lpage>4632</lpage><pub-id pub-id-type="doi">10.1210/jc.2003-030358</pub-id><pub-id pub-id-type="pmid">14557432</pub-id>
</element-citation><mixed-citation id="mc-CR115" publication-type="journal">Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88(10):4623&#x02013;32.<pub-id pub-id-type="pmid">14557432</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name><surname>Laupland</surname><given-names>KB</given-names></name><name><surname>Ramanan</surname><given-names>M</given-names></name><name><surname>Shekar</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>F</given-names></name><name><surname>Clement</surname><given-names>P</given-names></name><name><surname>Tabah</surname><given-names>A</given-names></name></person-group><article-title>Long-term outcome of prolonged critical illness: a multicentered study in North Brisbane, Australia</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><issue>4</issue><fpage>e0249840</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0249840</pub-id><pub-id pub-id-type="pmid">33831072</pub-id>
</element-citation><mixed-citation id="mc-CR116" publication-type="journal">Laupland KB, Ramanan M, Shekar K, Edwards F, Clement P, Tabah A. Long-term outcome of prolonged critical illness: a multicentered study in North Brisbane, Australia. PLoS ONE. 2021;16(4):e0249840.<pub-id pub-id-type="pmid">33831072</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Hong</surname><given-names>SB</given-names></name><name><surname>Lim</surname><given-names>CM</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name></person-group><article-title>Sequential organ failure assessment score and comorbidity: valuable prognostic indicators in chronically critically ill patients</article-title><source>Anaesth Intensive Care</source><year>2008</year><volume>36</volume><issue>4</issue><fpage>528</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1177/0310057X0803600422</pub-id><pub-id pub-id-type="pmid">18714621</pub-id>
</element-citation><mixed-citation id="mc-CR117" publication-type="journal">Lee K, Hong SB, Lim CM, Koh Y. Sequential organ failure assessment score and comorbidity: valuable prognostic indicators in chronically critically ill patients. Anaesth Intensive Care. 2008;36(4):528&#x02013;34.<pub-id pub-id-type="pmid">18714621</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Jayaraman</surname><given-names>D</given-names></name><name><surname>Shahin</surname><given-names>J</given-names></name></person-group><article-title>Association between initial ICU admission diagnosis and outcomes in chronic critically ill patients: a retrospective cohort study</article-title><source>Can J Respir Crit Care Sleep Med</source><year>2020</year><volume>4</volume><issue>3</issue><fpage>187</fpage><lpage>193</lpage></element-citation><mixed-citation id="mc-CR118" publication-type="journal">Yao H, Jayaraman D, Shahin J. Association between initial ICU admission diagnosis and outcomes in chronic critically ill patients: a retrospective cohort study. Can J Respir Crit Care Sleep Med. 2020;4(3):187&#x02013;93.</mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaukonen</surname><given-names>KM</given-names></name><name><surname>Bailey</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Pilcher</surname><given-names>D</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name></person-group><article-title>Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x02013;2012</article-title><source>JAMA</source><year>2014</year><volume>311</volume><issue>13</issue><fpage>1308</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.2637</pub-id><pub-id pub-id-type="pmid">24638143</pub-id>
</element-citation><mixed-citation id="mc-CR119" publication-type="journal">Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x02013;2012. JAMA. 2014;311(13):1308&#x02013;16.<pub-id pub-id-type="pmid">24638143</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name><surname>van Breugel</surname><given-names>JMM</given-names></name><name><surname>Niemeyer</surname><given-names>MJS</given-names></name><name><surname>Houwert</surname><given-names>RM</given-names></name><name><surname>Groenwold</surname><given-names>RHH</given-names></name><name><surname>Leenen</surname><given-names>LPH</given-names></name><name><surname>van Wessem</surname><given-names>KJP</given-names></name></person-group><article-title>Global changes in mortality rates in polytrauma patients admitted to the ICU-a systematic review</article-title><source>World J Emerg Surg</source><year>2020</year><volume>15</volume><issue>1</issue><fpage>55</fpage><pub-id pub-id-type="doi">10.1186/s13017-020-00330-3</pub-id><pub-id pub-id-type="pmid">32998744</pub-id>
</element-citation><mixed-citation id="mc-CR120" publication-type="journal">van Breugel JMM, Niemeyer MJS, Houwert RM, Groenwold RHH, Leenen LPH, van Wessem KJP. Global changes in mortality rates in polytrauma patients admitted to the ICU-a systematic review. World J Emerg Surg. 2020;15(1):55.<pub-id pub-id-type="pmid">32998744</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>WJ</given-names></name><name><surname>Ni</surname><given-names>ZY</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title><source>N Engl J Med</source><year>2020</year><volume>382</volume><issue>18</issue><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id><pub-id pub-id-type="pmid">32109013</pub-id>
</element-citation><mixed-citation id="mc-CR121" publication-type="journal">Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x02013;20.<pub-id pub-id-type="pmid">32109013</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JE</given-names></name><name><surname>Kinjo</surname><given-names>K</given-names></name><name><surname>Meier</surname><given-names>DE</given-names></name><name><surname>Ahmad</surname><given-names>K</given-names></name><name><surname>Morrison</surname><given-names>RS</given-names></name></person-group><article-title>When critical illness becomes chronic: informational needs of patients and families</article-title><source>J Crit Care</source><year>2005</year><volume>20</volume><issue>1</issue><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.jcrc.2004.11.003</pub-id><pub-id pub-id-type="pmid">16015521</pub-id>
</element-citation><mixed-citation id="mc-CR122" publication-type="journal">Nelson JE, Kinjo K, Meier DE, Ahmad K, Morrison RS. When critical illness becomes chronic: informational needs of patients and families. J Crit Care. 2005;20(1):79&#x02013;89.<pub-id pub-id-type="pmid">16015521</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>TR</given-names></name><name><surname>Bradley</surname><given-names>EH</given-names></name><name><surname>Towle</surname><given-names>VR</given-names></name><name><surname>Allore</surname><given-names>H</given-names></name></person-group><article-title>Understanding the treatment preferences of seriously ill patients</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>14</issue><fpage>1061</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1056/NEJMsa012528</pub-id><pub-id pub-id-type="pmid">11932474</pub-id>
</element-citation><mixed-citation id="mc-CR123" publication-type="journal">Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061&#x02013;6.<pub-id pub-id-type="pmid">11932474</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name><surname>de Cezar</surname><given-names>AG</given-names></name><name><surname>Castanhel</surname><given-names>FD</given-names></name><name><surname>Grosseman</surname><given-names>S</given-names></name></person-group><article-title>Needs of family members of patients in intensive care and their perception of medical communication</article-title><source>Crit Care Sci</source><year>2023</year><volume>35</volume><issue>1</issue><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.5935/2965-2774.20230374-en</pub-id><pub-id pub-id-type="pmid">37712732</pub-id>
</element-citation><mixed-citation id="mc-CR124" publication-type="journal">de Cezar AG, Castanhel FD, Grosseman S. Needs of family members of patients in intensive care and their perception of medical communication. Crit Care Sci. 2023;35(1):73&#x02013;83.<pub-id pub-id-type="pmid">37712732</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JE</given-names></name><name><surname>Tandon</surname><given-names>N</given-names></name><name><surname>Mercado</surname><given-names>AF</given-names></name><name><surname>Camhi</surname><given-names>SL</given-names></name><name><surname>Ely</surname><given-names>EW</given-names></name><name><surname>Morrison</surname><given-names>RS</given-names></name></person-group><article-title>Brain dysfunction: another burden for the chronically critically ill</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><issue>18</issue><fpage>1993</fpage><lpage>1999</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.18.1993</pub-id><pub-id pub-id-type="pmid">17030833</pub-id>
</element-citation><mixed-citation id="mc-CR125" publication-type="journal">Nelson JE, Tandon N, Mercado AF, Camhi SL, Ely EW, Morrison RS. Brain dysfunction: another burden for the chronically critically ill. Arch Intern Med. 2006;166(18):1993&#x02013;9.<pub-id pub-id-type="pmid">17030833</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>MM</given-names></name><name><surname>Thompson</surname><given-names>AE</given-names></name><name><surname>Lumb</surname><given-names>P</given-names></name><name><surname>Lacroix</surname><given-names>J</given-names></name><name><surname>St</surname><given-names>AA</given-names></name></person-group><article-title>Co-evolutions of pediatric and adult critical care</article-title><source>Crit Care Med</source><year>2021</year><volume>49</volume><issue>2</issue><fpage>188</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000004803</pub-id><pub-id pub-id-type="pmid">33438971</pub-id>
</element-citation><mixed-citation id="mc-CR126" publication-type="journal">Parker MM, Thompson AE, Lumb P, Lacroix J, St AA. Co-evolutions of pediatric and adult critical care. Crit Care Med. 2021;49(2):188&#x02013;200.<pub-id pub-id-type="pmid">33438971</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>